<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://bmjopen.bmj.com">
<title>BMJ Open Current Issue</title>
<link>http://bmjopen.bmj.com</link>
<description>BMJ Open RSS feed -- current issue</description>
<prism:coverDisplayDate>2013</prism:coverDisplayDate>
<prism:publicationName>BMJ Open</prism:publicationName>
<prism:issn>2044-6055</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002367?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002457?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002563?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002644?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002669?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002612?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002624?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002685?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002795?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002970?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002280?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002387?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002579?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002000?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002241?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002326?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002772?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002819?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e001541corr1?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002083corr1?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002331?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002497?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002538?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002578?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002067?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002224?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002378?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002399?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002413?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002540?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002607?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002758?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002521?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002604?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002640?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002713?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002789?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e001336?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002154?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002203?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002266?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002297?rss=1" />
  <rdf:li rdf:resource="http://bmjopen.bmj.com/cgi/content/short/3/5/e002346?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://bmjopen.bmj.com/site/homepage/BMJOPEN_95x60.gif" />
</channel>
<image rdf:about="http://bmjopen.bmj.com/site/homepage/BMJOPEN_95x60.gif">
<title>BMJ Open</title>
<url>http://bmjopen.bmj.com/site/homepage/BMJOPEN_95x60.gif</url>
<link>http://bmjopen.bmj.com</link>
</image>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002367?rss=1">
<title><![CDATA[Placing clinical variables on a common scale of empirically based risk]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002367?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To explore the hypothesis that placing clinical variables of differing metrics on a common linear scale of all-cause postdischarge mortality provides risk functions that are directly correlated with in-hospital mortality risk.</p>
</sec>
<sec><st>Design</st>
<p>Modelling study.</p>
</sec>
<sec><st>Setting</st>
<p>An 805-bed community hospital in the southeastern USA.</p>
</sec>
<sec><st>Participants</st>
<p>42302 inpatients admitted for any reason, excluding obstetrics, paediatric and psychiatric patients.</p>
</sec>
<sec><st>Outcome measures</st>
<p>All-cause in-hospital and postdischarge mortalities, and associated correlations.</p>
</sec>
<sec><st>Results</st>
<p>Pearson correlation coefficients comparing in-hospital risks with postdischarge risks for creatinine, heart rate and a set of 12 nursing assessments are 0.920, 0.922 and 0.892, respectively. Correlation between postdischarge risk heart rate and the Modified Early Warning System (MEWS) component for heart rate is 0.855. The minimal excess risk values for creatinine and heart rate roughly correspond to the normal reference ranges. We also provide the risks for values outside that range, independent of expert opinion or a regression model. By summing risk functions, a first-approximation patient risk score is created, which correctly ranks 6 discharge categories by average mortality with p&lt;0.001 for differences in category means, and Tukey's Honestly Significant Difference Test confirmed that the means were all different at the 95% confidence level.</p>
</sec>
<sec><st>Conclusions</st>
<p>Quantitative or categorical clinical variables can be transformed into risk functions that correlate well with in-hospital risk. This methodology provides an empirical way to assess inpatient risk from data available in the Electronic Health Record. With just the variables in this paper, we achieve a risk score that correlates with discharge disposition. This is the first step towards creation of a universal measure of patient condition that reflects a generally applicable set of health-related risks. More importantly, we believe that our approach opens the door to a way of exploring and resolving many issues in patient assessment.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Rothman, S. I., Rothman, M. J., Solinger, A. B.]]></dc:creator>
<dc:date>2013-05-14T21:19:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002367</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002367</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Health informatics, Research methods]]></dc:subject>
<dc:title><![CDATA[Placing clinical variables on a common linear scale of empirically based risk as a step towards construction of a general patient acuity score from the electronic health record: a modelling study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002367</prism:startingPage>
<prism:endingPage>e002367</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002457?rss=1">
<title><![CDATA[Predictive models for diabetes and hypertension in Kuwait]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002457?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>We build classification models and risk assessment tools for diabetes, hypertension and comorbidity using machine-learning algorithms on data from Kuwait. We model the increased proneness in diabetic patients to develop hypertension and vice versa. We ascertain the importance of ethnicity (and natives vs expatriate migrants) and of using regional data in risk assessment.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective cohort study. Four machine-learning techniques were used: logistic regression, k-nearest neighbours (k-NN), multifactor dimensionality reduction and support vector machines. The study uses fivefold cross validation to obtain generalisation accuracies and errors.</p>
</sec>
<sec><st>Setting</st>
<p>Kuwait Health Network (KHN) that integrates data from primary health centres and hospitals in Kuwait.</p>
</sec>
<sec><st>Participants</st>
<p>270&nbsp;172 hospital visitors (of which, 89&nbsp;858 are diabetic, 58&nbsp;745 hypertensive and 30&nbsp;522 comorbid) comprising Kuwaiti natives, Asian and Arab expatriates.</p>
</sec>
<sec><st>Outcome measures</st>
<p>Incident type 2 diabetes, hypertension and comorbidity.</p>
</sec>
<sec><st>Results</st>
<p>Classification accuracies of &gt;85% (for diabetes) and &gt;90% (for hypertension) are achieved using only simple non-laboratory-based parameters. Risk assessment tools based on k-NN classification models are able to assign &lsquo;high&rsquo; risk to 75% of diabetic patients and to 94% of hypertensive patients. Only 5% of diabetic patients are seen assigned &lsquo;low&rsquo; risk. Asian-specific models and assessments perform even better. Pathological conditions of diabetes in the general population or in hypertensive population and those of hypertension are modelled. Two-stage aggregate classification models and risk assessment tools, built combining both the component models on diabetes (or on hypertension), perform better than individual models.</p>
</sec>
<sec><st>Conclusions</st>
<p>Data on diabetes, hypertension and comorbidity from the cosmopolitan State of Kuwait are available for the first time. This enabled us to apply four different case&ndash;control models to assess risks. These tools aid in the preliminary non-intrusive assessment of the population. Ethnicity is seen significant to the predictive models. Risk assessments need to be developed using regional data as we demonstrate the applicability of the American Diabetes Association online calculator on data from Kuwait.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Farran, B., Channanath, A. M., Behbehani, K., Thanaraj, T. A.]]></dc:creator>
<dc:date>2013-05-14T21:19:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002457</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002457</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Diabetes and endocrinology, Epidemiology, Health informatics, Public health, Research methods]]></dc:subject>
<dc:title><![CDATA[Predictive models to assess risk of type 2 diabetes, hypertension and comorbidity: machine-learning algorithms and validation using national health data from Kuwait--a cohort study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002457</prism:startingPage>
<prism:endingPage>e002457</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002563?rss=1">
<title><![CDATA[Cardiac arrest in general practice]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002563?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To document the involvement of general practitioners (GPs) in cardiac arrests with resuscitation attempts (CARAs) and to describe the outcomes.</p>
</sec>
<sec><st>Design</st>
<p>A 5-year prospective cross-sectional study of GPs in Ireland equipped with automated external defibrillators (AEDs) and immediate care training by the MERIT Project, with data collection every 3&nbsp;months over the 5-year period. Practices reported CARAs by quarterly survey with an 89% mean response rate (81&ndash;97% for the period).</p>
</sec>
<sec><st>Setting</st>
<p>General practices throughout Ireland.</p>
</sec>
<sec><st>Participants</st>
<p>495 GP participated: 168 (33.9%) urban, 163 (32.9%) rural and 164 (33.1%) mixed.</p>
</sec>
<sec><st>Interventions</st>
<p>All participating practices received a standard AED and basic life support kit. Training in immediate care was provided for at least one GP in the practice.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Incidence of CARA in participating practices. Return of spontaneous circulation (ROSC) and discharge alive from hospital.</p>
</sec>
<sec><st>Results</st>
<p>36% of practices were involved in a CARA during the 5-year period and 13% were involved in more than one CARA. Of the 272 CARAs reported, ROSC occurred in 32% (87/272) and discharge from hospital in 18.7% (49/262). In 45% of cases, the first AED was brought by the GP and in 65%, the GP arrived before the ambulance service. More cases occurred in rural and mixed settings than urban ones, but the survival rates did not differ between areas. In 65% of cases, the GP was on duty at the time of the incident and 47% of cases occurred in the patient's home.</p>
</sec>
<sec><st>Conclusions</st>
<p>These outcomes are comparable with more highly structured components of the emergency response system and indicate that GPs have an important role to play in the care of patients in their own communities. GPs experience cardiac arrest cases during the course of their daily work and provide prompt care which results in successful outcomes in urban, mixed and rural settings.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bury, G., Headon, M., Egan, M., Dowling, J.]]></dc:creator>
<dc:date>2013-05-14T21:19:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002563</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002563</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Cardiovascular medicine, Emergency medicine, General practice / Family practice]]></dc:subject>
<dc:title><![CDATA[Cardiac arrest management in general practice in Ireland: a 5-year cross-sectional study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002563</prism:startingPage>
<prism:endingPage>e002563</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002644?rss=1">
<title><![CDATA[Physical activity and health status among adolescents]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002644?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Little is known about the dose&ndash;response relationship between physical activity and health benefits among young people. Our objective was to analyse the association between the frequency of undertaking moderate-to-vigorous physical activity (MVPA) and the self-reported health status of the adolescent population.</p>
</sec>
<sec><st>Design</st>
<p>Cross-sectional study.</p>
</sec>
<sec><st>Setting</st>
<p>All regions of Spain.</p>
</sec>
<sec><st>Participants</st>
<p>Students aged 11&ndash;18&nbsp;years participating in the Spanish Health Behaviour in School-aged Children survey 2006. A total of 375 schools and 21&nbsp;188 students were selected.</p>
</sec>
<sec><st>Main outcomes</st>
<p>The frequency of undertaking MVPA was measured by a questionnaire, with the following four health indicators: self-rated health, health complaints, satisfaction with life and health-related quality of life. Linear and logistic regression models were used to analyse the association, adjusting for potential confounding variables and the modelling of the dose&ndash;response relationship.</p>
</sec>
<sec><st>Results</st>
<p>As the frequency of MVPA increased, the association with health benefits was stronger. A linear trend (p&lt;0.05) was found for self-rated health and health complaints in males and females and for satisfaction with life among females; for health-related quality of life this relationship was quadratic for both sexes (p&lt;0.05). For self-reported health and health complaints, the effect was found to be of greater magnitude in males than in females and, in all scales, the benefits were observed from the lowest frequencies of MVPA, especially in males.</p>
</sec>
<sec><st>Conclusions</st>
<p>A protective effect of MVPA was found in both sexes for the four health indicators studied, and this activity had a gradient effect. Among males, health benefits were detected from very low levels of physical activity and the magnitude of the relationship was greater than that for females.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Galan, I., Boix, R., Medrano, M. J., Ramos, P., Rivera, F., Pastor-Barriuso, R., Moreno, C.]]></dc:creator>
<dc:date>2013-05-14T21:19:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002644</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002644</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Public health, Sports and exercise medicine]]></dc:subject>
<dc:title><![CDATA[Physical activity and self-reported health status among adolescents: a cross-sectional population-based study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002644</prism:startingPage>
<prism:endingPage>e002644</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002669?rss=1">
<title><![CDATA[Overweight and empowerment: a study protocol]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002669?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Obesity is a growing health problem in Europe and it causes many diseases. Many weight-reducing methods are reported in medical literature, but none of them proved to be effective in maintaining the results achieved over time. Self-empowerment can be an important innovative method, but an effectiveness study is necessary. In order to standardise the procedures for a randomised controlled study, a pilot study will be run to observe, measure and evaluate the effects of a period of self-empowerment group treatment on overweight/obese patients.</p>
</sec>
<sec><st>Methods</st>
<p>and analysis Non-controlled, experimental, pilot study. A selected group of patients with body mass index &gt;25, with no severe psychiatric disorders, with no aesthetic or therapeutic motivation will be included in the study. A set of quantitative and qualitative measures will be utilised to evaluate the effects of a self-empowerment course in a 12&nbsp;month time. Group therapy and medical examinations will also complete this observational phase. At the end of this pilot study, a set of appropriate measures and procedures to determine the effectiveness of individual empowerment will be identified and agreed among the different professional figures. Results will be recorded and analysed to start a randomised controlled trial to evaluate the effectiveness of the proposed methodology.</p>
</sec>
<sec><st>Ethics and dissemination</st>
<p>This protocol was approved by the local Ethics Committee of Udine in March 2012. The findings of the trial will be disseminated through peer-reviewed journals, national and international conference presentations and public events involving the local administrations of the towns where the trial participants are resident.</p>
</sec>
<sec><st>Trial Registration</st>
<p><A HREF="http://www.clinicalstrials.gov">http://www.clinicalstrials.gov</A> identifier NCT01644708.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Struzzo, P., Fumato, R., Tillati, S., Cacitti, A., Gangi, F., Stefani, A., Torcutti, A., Crapesi, L., Tubaro, G., Balestrieri, M.]]></dc:creator>
<dc:date>2013-05-14T21:19:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002669</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002669</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Health services research, Mental health, Nutrition and metabolism]]></dc:subject>
<dc:title><![CDATA[Individual empowerment in overweight and obese patients: a study protocol]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Protocol</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002669</prism:startingPage>
<prism:endingPage>e002669</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002612?rss=1">
<title><![CDATA[Sex-selective abortion in Nepal]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002612?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To quantify trends in changing sex ratios of births before and after the legalisation of abortion in Nepal. While sex-selective abortion is common in some Asian countries, it is not clear whether the legal status of abortion is associated with the prevalence of sex-selection when sex-selection is illegal. In this context, Nepal provides an interesting case study. Abortion was legalised in 2002 and prior to that, there was no evidence of sex-selective abortion. Changes in the sex ratio at birth since legalisation would suggest an association with legalisation, even though sex-selection is expressly prohibited.</p>
</sec>
<sec><st>Design</st>
<p>Analysis of data from four Demographic and Health Surveys, conducted in 1996, 2001, 2006 and 2011.</p>
</sec>
<sec><st>Setting</st>
<p>Nepal.</p>
</sec>
<sec><st>Participants</st>
<p>31&nbsp;842 women aged 15&ndash;49.</p>
</sec>
<sec><st>Main outcome measure</st>
<p>Conditional sex ratios (CSRs) were calculated, specifically the CSR for second-born children where the first-born was female. This CSR is where the evidence of sex-selective abortion will be most visible. CSRs were looked at over time to assess the impact of legalisation as well as for population sub-groups in order to identify characteristics of women using sex-selection.</p>
</sec>
<sec><st>Results</st>
<p>From 2007 to 2010, the CSR for second-order births where the first-born was a girl was found to be 742 girls per 1000 boys (95% CI 599 to 913). Prior to legalisation of abortion (1998&ndash;2000), the same CSR was 1021 (906&ndash;1150). After legalisation, it dropped most among educated and richer women, especially in urban areas. Just 325 girls were born for every 1000 boys among the richest urban women.</p>
</sec>
<sec><st>Conclusions</st>
<p>The fall in CSRs witnessed post-legalisation indicates that sex-selective abortion is becoming more common. This change is very likely driven by both supply and demand factors. Falling fertility has intensified the need to bear a son sooner, while legal abortion services have reduced the costs and risks associated with obtaining an abortion.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Frost, M. D., Puri, M., Hinde, P. R. A.]]></dc:creator>
<dc:date>2013-05-14T08:57:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002612</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002612</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Global health, Health policy, Public health]]></dc:subject>
<dc:title><![CDATA[Falling sex ratios and emerging evidence of sex-selective abortion in Nepal: evidence from nationally representative survey data]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002612</prism:startingPage>
<prism:endingPage>e002612</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002624?rss=1">
<title><![CDATA[Cardiovascular disease among osteoarthritis patients]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002624?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Our objective was to determine the relationship between osteoarthritis (OA) and heart diseases (myocardial infarction (MI), angina, congestive heart failure (CHF)) and stroke using population-based survey data.</p>
</sec>
<sec><st>Design</st>
<p>Cross-sectional study.</p>
</sec>
<sec><st>Setting</st>
<p>Canadian Community Health Survey (CCHS).</p>
</sec>
<sec><st>Participants</st>
<p>Adult participants in the CCHS cycles 1.1, 2.1 and 3.1 were included. CCHS provides nationally representative data on health determinants, health status and health system utilisation. We have identified 40&nbsp;817 self-reported OA subjects and selected 1:1 matched non-OA respondents by age, sex and CCHS cycles.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Self-reported heart disease was the primary outcome and MI, angina, CHF and stroke were considered as secondary outcomes. Multivariable logistic regression models were used to estimate the ORs after adjusting for sociodemographic status, obesity, physical activity, smoking status, fruit and vegetable consumption, medication use, diabetes, hypertension and chronic obstructive pulmonary disease.</p>
</sec>
<sec><st>Results</st>
<p>The mean age of OA cases was 66&nbsp;years and 71.6% were women. OA exhibited increased odds of prevalent heart disease, and adjusted overall OR (95% CI) was 1.45 (1.36 to 1.54), 1.35 (1.21 to 1.50) among men and 1.51 (1.39 to 1.64) among women with OA. OA showed increased ORs for angina and CHF in both men and women, and for MI in women. ORs (95% CI) for men and women, respectively, were 1.08 (0.91 to 1.28) and 1.49 (1.28 to 1.75) for MI, 1.76 (1.43 to 2.17) and 1.84 (1.59 to 2.14) for angina, 1.50 (1.13 to 1.97) and 1.81 (1.49 to 2.21) for CHF, and 1.08 (0.83 to 1.40) and 1.13 (0.93 to 1.37) for stroke.</p>
</sec>
<sec><st>Conclusions</st>
<p>Prevalent OA was associated with self-reported heart disease, particularly angina, and CHF in both men and women, after controlling for established risk factors for these conditions. This study provides a rationale for further investigation of the association between OA and heart disease in longitudinal studies for investigating possible biological and behavioural mechanisms.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Rahman, M. M., Kopec, J. A., Cibere, J., Goldsmith, C. H., Anis, A. H.]]></dc:creator>
<dc:date>2013-05-14T08:57:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002624</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002624</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Rheumatology]]></dc:subject>
<dc:title><![CDATA[The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002624</prism:startingPage>
<prism:endingPage>e002624</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002685?rss=1">
<title><![CDATA[Cambodia's case study to address human resources crisis and maternal mortality]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002685?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To identify factors that have contributed to the systematic development of the Cambodian human resources for health (HRH) system with a focus on midwifery services in response to high maternal mortality in fragile resource-constrained countries.</p>
</sec>
<sec><st>Design</st>
<p>Qualitative case study. Review of the published and grey literature and in-depth interviews with key informants and stakeholders using an HRH system conceptual framework developed by the authors (&lsquo;House Model&rsquo;; Fujita et al, 2011). Interviews focused on the perceptions of respondents regarding their contributions to strengthening midwifery services and the other external influences which may have influenced the HRH system and reduction in the maternal mortality ratio (MMR).</p>
</sec>
<sec><st>Setting</st>
<p>Three rounds of interviews were conducted with senior and mid-level managers of the Ministries of Health (MoH) and Education, educational institutes and development partners.</p>
</sec>
<sec><st>Participants</st>
<p>A total of 49 interviewees, who were identified through a snowball sampling technique.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Scaling up the availability of 24&nbsp;h maternal health services at all health centres contributing to MMR reduction.</p>
</sec>
<sec><st>Results</st>
<p>The incremental development of the Cambodian HRH system since 2005 focused on the production, deployment and retention of midwives in rural areas as part of a systematic strategy to reduce maternal mortality. The improved availability and access to midwifery services contributed to significant MMR reduction. Other contributing factors included improved mechanisms for decision-making and implementation; political commitment backed up with necessary resources; leadership from the top along with a growing capacity of mid-level managers; increased MoH capacity to plan and coordinate; and supportive development partners in the context of a conducive external environment.</p>
</sec>
<sec><st>Conclusions</st>
<p>Lessons from this case study point to the importance of a systemic and comprehensive approach to health and HRH system strengthening and of ongoing capacity enhancement and leadership development to ensure effective planning, implementation and monitoring of HRH policies and strategies.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Fujita, N., Abe, K., Rotem, A., Tung, R., Keat, P., Robins, A., Zwi, A. B.]]></dc:creator>
<dc:date>2013-05-14T08:57:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002685</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002685</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Health policy, Public health]]></dc:subject>
<dc:title><![CDATA[Addressing the human resources crisis: a case study of Cambodia's efforts to reduce maternal mortality (1980-2012)]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002685</prism:startingPage>
<prism:endingPage>e002685</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002795?rss=1">
<title><![CDATA[Nocturnal sweating in sleep apnoea]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002795?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To estimate the prevalence and characteristics of frequent nocturnal sweating in obstructive sleep apnoea (OSA) patients compared with the general population and evaluate the possible changes with positive airway pressure (PAP) treatment. Nocturnal sweating can be very bothersome to the patient and bed partner.</p>
</sec>
<sec><st>Design</st>
<p>Case&ndash;control and longitudinal cohort study.</p>
</sec>
<sec><st>Setting</st>
<p>Landspitali&mdash;The National University Hospital, Iceland.</p>
</sec>
<sec><st>Participants</st>
<p>The Icelandic Sleep Apnea Cohort consisted of 822 untreated patients with OSA, referred for treatment with PAP. Of these, 700 patients were also assessed at a 2-year follow-up. The control group consisted of 703 randomly selected subjects from the general population.</p>
</sec>
<sec><st>Intervention</st>
<p>PAP therapy in the OSA cohort.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Subjective reporting of nocturnal sweating on a frequency scale of 1&ndash;5: (1) never or very seldom, (2) less than once a week, (3) once to twice a week, (4) 3&ndash;5 times a week and (5) every night or almost every night. Full PAP treatment was defined objectively as the use for &ge;4&nbsp;h/day and &ge;5&nbsp;days/week.</p>
</sec>
<sec><st>Results</st>
<p>Frequent nocturnal sweating (&ge;3<FONT FACE="arial,helvetica">x</FONT> a week) was reported by 30.6% of male and 33.3% of female OSA patients compared with 9.3% of men and 12.4% of women in the general population (p&lt;0.001). This difference remained significant after adjustment for demographic factors. Nocturnal sweating was related to younger age, cardiovascular disease, hypertension, sleepiness and insomnia symptoms. The prevalence of frequent nocturnal sweating decreased with full PAP treatment (from 33.2% to 11.5%, p&lt;0.003 compared with the change in non-users).</p>
</sec>
<sec><st>Conclusions</st>
<p>The prevalence of frequent nocturnal sweating was threefold higher in untreated OSA patients than in the general population and decreased to general population levels with successful PAP therapy. Practitioners should consider the possibility of OSA in their patients who complain of nocturnal sweating.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Arnardottir, E. S., Janson, C., Bjornsdottir, E., Benediktsdottir, B., Juliusson, S., Kuna, S. T., Pack, A. I., Gislason, T.]]></dc:creator>
<dc:date>2013-05-14T08:57:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002795</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002795</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, General practice / Family practice, Public health, Respiratory medicine]]></dc:subject>
<dc:title><![CDATA[Nocturnal sweating--a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002795</prism:startingPage>
<prism:endingPage>e002795</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002970?rss=1">
<title><![CDATA[Sustainability of knowledge translation interventions: a scoping review protocol]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002970?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Knowledge translation (KT also known as research utilisation, translational medicine and implementation science) is a dynamic and iterative process that includes the synthesis, dissemination, exchange and ethically sound application of knowledge to improve health. After the implementation of KT interventions, their impact on relevant outcomes should be monitored. The objectives of this scoping review are to: (1) conduct a systematic search of the literature to identify the impact on healthcare outcomes beyond 1&nbsp;year, or beyond the termination of funding of the initiative of KT interventions targeting chronic disease management for end-users including patients, clinicians, public health officials, health services managers and policy-makers; (2) identify factors that influence sustainability of effective KT interventions; (3) identify how sustained change from KT interventions should be measured; and (4) develop a framework for assessing sustainability of KT interventions.</p>
</sec>
<sec><st>Methods and analysis</st>
<p>Comprehensive searches of relevant electronic databases (eg, MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials), websites of funding agencies and websites of healthcare provider organisations will be conducted to identify relevant material. We will include experimental, quasi-experimental and observational studies providing information on the sustainability of KT interventions targeting chronic disease management in adults and focusing on end-users including patients, clinicians, public health officials, health services managers and policy-makers. Two reviewers will pilot-test the screening criteria and data abstraction form. They will then screen all citations, full articles and abstract data in duplicate independently. The results of the scoping review will be synthesised descriptively and used to develop a framework to assess the sustainability of KT interventions.</p>
</sec>
<sec><st>Discussion and dissemination</st>
<p>Our results will help inform end-users (ie, patients, clinicians, public health officials, health services managers and policy-makers) regarding the sustainability of KT interventions. Our dissemination plan includes publications, presentations, website posting and a stakeholder meeting.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Tricco, A. C., Cogo, E., Ashoor, H., Perrier, L., McKibbon, K. A., Grimshaw, J. M., Straus, S. E.]]></dc:creator>
<dc:date>2013-05-14T08:57:52-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002970</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002970</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Health services research]]></dc:subject>
<dc:title><![CDATA[Sustainability of knowledge translation interventions in healthcare decision-making: protocol for a scoping review]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Protocol</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002970</prism:startingPage>
<prism:endingPage>e002970</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002280?rss=1">
<title><![CDATA[Dietary {alpha}-linolenic acid intake and prostate cancer risk: a meta-analysis]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002280?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>&alpha;-Linolenic acid (ALA) is considered to be a cardioprotective nutrient; however, some epidemiological studies have suggested that dietary ALA intake increases the risk of prostate cancer. The main objective was to conduct a systematic review and meta-analysis of case&ndash;control and prospective studies investigating the association between dietary ALA intake and prostate cancer risk.</p>
</sec>
<sec><st>Design</st>
<p>A systematic review and meta-analysis were conducted by searching MEDLINE and EMBASE for relevant prospective and case&ndash;control studies.</p>
</sec>
<sec><st>Included studies</st>
<p>We included all prospective cohort, case&ndash;control, nested case-cohort and nested case&ndash;control studies that investigated the effect of dietary ALA intake on the incidence (or diagnosis) of prostate cancer and provided relative risk (RR), HR or OR estimates.</p>
</sec>
<sec><st>Primary outcome measure</st>
<p>Data were pooled using the generic inverse variance method with a random effects model from studies that compared the highest ALA quantile with the lowest ALA quantile. Risk estimates were expressed as RR with 95% CIs. Heterogeneity was assessed by <sup>2</sup> and quantified by I<sup>2</sup>.</p>
</sec>
<sec><st>Results</st>
<p>Data from five prospective and seven case&ndash;control studies were pooled. The overall RR estimate showed ALA intake to be positively but non-significantly associated with prostate cancer risk (1.08 (0.90 to 1.29), p=0.40; I<sup>2</sup>=85%), but the interpretation was complicated by evidence of heterogeneity not explained by study design. A weak, non-significant protective effect of ALA intake on prostate cancer risk in the prospective studies became significant (0.91 (0.83 to 0.99), p=0.02) without evidence of heterogeneity (I<sup>2</sup>=8%, p=0.35) on removal of one study during sensitivity analyses.</p>
</sec>
<sec><st>Conclusions</st>
<p>This analysis failed to confirm an association between dietary ALA intake and prostate cancer risk. Larger and longer observational and interventional studies are needed to define the role of ALA and prostate cancer.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Carleton, A. J., Sievenpiper, J. L., de Souza, R., McKeown-Eyssen, G., Jenkins, D. J. A.]]></dc:creator>
<dc:date>2013-05-14T08:57:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002280</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002280</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Nutrition and metabolism, Oncology, Urology]]></dc:subject>
<dc:title><![CDATA[Case-control and prospective studies of dietary {alpha}-linolenic acid intake and prostate cancer risk: a meta-analysis]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002280</prism:startingPage>
<prism:endingPage>e002280</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002387?rss=1">
<title><![CDATA[Determinants of vulnerability in early childhood development in Ireland]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002387?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Early childhood development strongly influences lifelong health. The Early Development Instrument (EDI) is a well-validated population-level measure of five developmental domains (physical health and well-being, social competence, emotional maturity, language and cognitive skills, and communication skills and general knowledge) at school entry age. The aim of this study was to explore the potential of EDI as an indicator of early development in Ireland.</p>
</sec>
<sec><st>Design</st>
<p>A cross-sectional design was used.</p>
</sec>
<sec><st>Setting</st>
<p>The study was conducted in 42 of 47 primary schools in a major Irish urban centre.</p>
</sec>
<sec><st>Participants</st>
<p>EDI (teacher completed) scores were calculated for 1243 children in their first year of full-time education. Contextual data from a subset of 865 children were collected using a parental questionnaire.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>Children scoring in the lowest 10% of the population in one or more domains were deemed &lsquo;developmentally vulnerable&rsquo;. Scores were correlated with contextual data from the parental questionnaire.</p>
</sec>
<sec><st>Results</st>
<p>In the sample population, 29% of children were not developmentally ready to engage in school. Factors associated with increased risk of vulnerability were being male OR 2.1 (CI 1.6 to 2.7); under 5&nbsp;years OR 1.5 (CI 1.1 to 2.1) and having English as a second language OR 3.7 (CI 2.6 to 5.2). Adjusted for these demographics, low birth weight, poor parent/child interaction and mother's lower level of education showed the most significant ORs for developmental vulnerability. Calculating population attributable fractions, the greatest population-level risk factors were being male (35%), mother's education (27%) and having English as a second language (12%).</p>
</sec>
<sec><st>Conclusions</st>
<p>The EDI and linked parental questionnaires are promising indicators of the extent, distribution and determinants of developmental vulnerability among children in their first year of primary school in Ireland.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Curtin, M., Madden, J., Staines, A., Perry, I. J.]]></dc:creator>
<dc:date>2013-05-14T08:57:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002387</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002387</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Paediatrics, Public health]]></dc:subject>
<dc:title><![CDATA[Determinants of vulnerability in early childhood development in Ireland: a cross-sectional study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002387</prism:startingPage>
<prism:endingPage>e002387</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002579?rss=1">
<title><![CDATA[Cost-effectiveness of a telephone-delivered caries prevention programme]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002579?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Early childhood caries is a highly destructive dental disease which is compounded by the need for young children to be treated under general anaesthesia. In Australia, there are long waiting periods for treatment at public hospitals. In this paper, we examined the costs and patient outcomes of a prevention programme for early childhood caries to assess its value for government services.</p>
</sec>
<sec><st>Design</st>
<p>Cost-effectiveness analysis using a Markov model.</p>
</sec>
<sec><st>Setting</st>
<p>Public dental patients in a low socioeconomic, socially disadvantaged area in the State of Queensland, Australia.</p>
</sec>
<sec><st>Participants</st>
<p>Children aged 6&nbsp;months to 6&nbsp;years received either a telephone prevention programme or usual care.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>A mathematical model was used to assess caries incidence and public dental treatment costs for a cohort of children. Healthcare costs, treatment probabilities and caries incidence were modelled from 6&nbsp;months to 6&nbsp;years of age based on trial data from mothers and their children who received either a telephone prevention programme or usual care. Sensitivity analyses were used to assess the robustness of the findings to uncertainty in the model estimates.</p>
</sec>
<sec><st>Results</st>
<p>By age 6&nbsp;years, the telephone intervention programme had prevented an estimated 43 carious teeth and saved &pound;69&nbsp;984 in healthcare costs per 100 children. The results were sensitive to the cost of general anaesthesia (cost-savings range &pound;36&nbsp;043&ndash;&pound;97&nbsp;298) and the incidence of caries in the prevention group (cost-savings range &pound;59&nbsp;496&ndash;&pound;83&nbsp;368) and usual care (cost-savings range &pound;46&nbsp;833&ndash;&pound;93&nbsp;328), but there were cost savings in all scenarios.</p>
</sec>
<sec><st>Conclusions</st>
<p>A telephone intervention that aims to prevent early childhood caries is likely to generate considerable and immediate patient benefits and cost savings to the public dental health service in disadvantaged communities.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pukallus, M., Plonka, K., Kularatna, S., Gordon, L., Barnett, A. G., Walsh, L., Seow, W. K.]]></dc:creator>
<dc:date>2013-05-14T08:57:51-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002579</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002579</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Dentistry and oral medicine, Health economics, Paediatrics]]></dc:subject>
<dc:title><![CDATA[Cost-effectiveness of a telephone-delivered education programme to prevent early childhood caries in a disadvantaged area: a cohort study]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002579</prism:startingPage>
<prism:endingPage>e002579</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002000?rss=1">
<title><![CDATA[Psychomotor development of children born in a vitamin A supplementation trial]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002000?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine the effects of maternal vitamin A supplementation from preconception through postpartum on cognitive and motor development of children at 10&ndash;13&nbsp;years of age in rural Nepal.</p>
</sec>
<sec><st>Design</st>
<p>Follow-up assessment of children born to women randomly assigned by a village to receive either supplemental vitamin A (7000&nbsp;&micro;g retinol equivalents) or placebo weekly during a continuous 3.5-year period from 1994&ndash;1997. The participants came from 12 wards, a subset of 270 wards in the original trial. Trained staff tested children for cognition by the Universal Nonverbal Intelligence Test (UNIT) and motor ability using four subtests from the Movement Assessment Battery for Children (MABC). Data on schooling, home environment and nutritional and socioeconomic status were also collected.</p>
</sec>
<sec><st>Setting</st>
<p>Southern plains district of Sarlahi, Nepal.</p>
</sec>
<sec><st>Participants</st>
<p>390 Nepalese children 10&ndash;13&nbsp;years of age.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Raw scores on UNIT and square-root transformed scores on an abridged version of the MABC tests, expressed as cluster-summarised (mean&plusmn;SD) values to account for the design of the original trial.</p>
</sec>
<sec><st>Results</st>
<p>There were no differences in UNIT (79.61&plusmn;5.99 vs 80.69&plusmn;6.71) or MABC (2.64&plusmn;0.07 vs 2.49&plusmn;0.09) test scores in children whose mothers were exposed to vitamin A vs placebo (mean differences: &ndash;1.07, 95% CI &ndash;7.10 to 9.26, p=0.78; 0.15, 95% CI 0.43 to &ndash;0.08, p=0.15), respectively. More children in the placebo group had repeated a grade in school (28% of placebo vs 16.7% of vitamin A, p=0.01).</p>
</sec>
<sec><st>Conclusions</st>
<p>Preconceptional to postpartum maternal vitamin A supplementation, in an undernourished setting, does not improve cognition or motor development at ages 10&ndash;13&nbsp;years.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Buckley, G. J., Murray-Kolb, L. E., Khatry, S. K., LeClerq, S. C., Wu, L., West, K. P., Christian, P.]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002000</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002000</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Global health, Neurology, Nutrition and metabolism, Paediatrics]]></dc:subject>
<dc:title><![CDATA[Cognitive and motor skills in school-aged children following maternal vitamin A supplementation during pregnancy in rural Nepal: a follow-up of a placebo-controlled, randomised cohort]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002000</prism:startingPage>
<prism:endingPage>e002000</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002241?rss=1">
<title><![CDATA[Impact of patients on OMERACT conferences]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002241?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To assess the inclusion of patients as international research partners in Outcome Measures in Rheumatology (OMERACT) conferences and how this has influenced the scope and conduct of outcomes research in rheumatology.</p>
</sec>
<sec><st>Design</st>
<p>A thematic content analysis of OMERACT internal documents, publications and conference proceedings, followed by a responsive evaluation including 32 qualitative semistructured interviews.</p>
</sec>
<sec><st>Setting</st>
<p>The international, biannual research conference OMERACT 10 (Malaysia, 2010).</p>
</sec>
<sec><st>Participants</st>
<p>Senior researchers (n=10), junior researchers (n=2), representatives of the pharmaceutical industry and regulators (n=2), conference staff (n=2), new patient delegates (n=8) and experienced patient delegates (n=8).</p>
</sec>
<sec><st>Results</st>
<p>The role of patients evolved over 10&nbsp;years from a single patient focus group to full participation in all areas of the meeting and inclusion in research group meetings between conferences. Five main categories of impact emerged: widening the research agenda; including patient relevant outcomes in core sets; enhancing patient reported instruments; changing the culture of OMERACT and consequences outside OMERACT. Patient participants identified previously neglected outcome domains such as fatigue, sleep disturbances and flares which prompted collaborative working on new programmes of research. Specific benefits and challenges for patients and professionals were identified, such as personal fulfilment, widening of research interests, difficulties in establishing equal partnerships and concerns about loss of research rigour.</p>
</sec>
<sec><st>Conclusions</st>
<p>Including patients as partners in OMERACT conferences has widened its focus and adjusted the way of working. It has resulted in new developments in the research agenda and the use of more patient-relevant outcomes in clinical trials. These collaborations have influenced perceptions and beliefs among many patients and researchers, and led to wider patient involvement as partners in research.</p>
</sec>
]]></description>
<dc:creator><![CDATA[de Wit, M., Abma, T., Koelewijn-van Loon, M., Collins, S., Kirwan, J.]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002241</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002241</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Patient-centred medicine, Qualitative research, Rheumatology]]></dc:subject>
<dc:title><![CDATA[Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002241</prism:startingPage>
<prism:endingPage>e002241</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002326?rss=1">
<title><![CDATA[Quality of facility newborn care in Ghana]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002326?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To assess the structural capacity for, and quality of, immediate and essential newborn care (ENC) in health facilities in rural Ghana, and to link this with demand for facility deliveries and admissions.</p>
</sec>
<sec><st>Design</st>
<p>Health facility assessment survey and population-based surveillance data.</p>
</sec>
<sec><st>Setting</st>
<p>Seven districts in Brong Ahafo Region, Ghana.</p>
</sec>
<sec><st>Participants</st>
<p>Heads of maternal/neonatal wards in all 64 facilities performing deliveries.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Indicators include: the availability of essential infrastructure, newborn equipment and drugs, and personnel; vignette scores and adequacy of reasons given for delayed discharge of newborn babies; and prevalence of key immediate ENC practices that facilities should promote. These are matched to the percentage of babies delivered in and admitted to each type of facility.</p>
</sec>
<sec><st>Results</st>
<p>70% of babies were delivered in health facilities; 56% of these and 87% of neonatal admissions were in four referral level hospitals. These had adequate infrastructure, but all lacked staff trained in ENC and some essential equipment (including incubators and bag and masks) and/or drugs. Vignette scores for care of very low-birth-weight babies were generally moderate-to-high, but only three hospitals achieved high overall scores for quality of ENC. We estimate that only 33% of babies were born in facilities capable of providing high quality, basic resuscitation as assessed by a vignette plus the presence of a bag and mask. Promotion of immediate ENC practices in facilities was also inadequate, with coverage of early initiation of breastfeeding and delayed bathing both below 50% for babies born in facilities; this represents a lost opportunity.</p>
</sec>
<sec><st>Conclusions</st>
<p>Unless major gaps in ENC equipment, drugs, staff, practices and skills are addressed, strategies to increase facility utilisation will not achieve their potential to save newborn lives.</p>
</sec>
<sec><st>Trial registration</st>
<p>http://clinicaltrials.gov NCT00623337.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Vesel, L., Manu, A., Lohela, T. J., Gabrysch, S., Okyere, E., ten Asbroek, A. H. A., Hill, Z., Agyemang, C. T., Owusu-Agyei, S., Kirkwood, B. R.]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002326</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002326</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Health services research, Paediatrics]]></dc:subject>
<dc:title><![CDATA[Quality of newborn care: a health facility assessment in rural Ghana using survey, vignette and surveillance data]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002326</prism:startingPage>
<prism:endingPage>e002326</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002772?rss=1">
<title><![CDATA[Lifecourse models of SES and psychological distress]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002772?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Early life factors, like intelligence and socioeconomic status (SES), are associated with health outcomes in adulthood. Fitting comprehensive life-course models, we tested (1) the effect of childhood intelligence and SES, education and adulthood SES on psychological distress at midlife, and (2) compared alternative measurement specifications (reflective and formative) of SES.</p>
</sec>
<sec><st>Design</st>
<p>Prospective cohort study (the Aberdeen Children of the 1950s).</p>
</sec>
<sec><st>Setting</st>
<p>Aberdeen, Scotland.</p>
</sec>
<sec><st>Participants</st>
<p>12&nbsp;500 live-births (6282 boys) between 1950 and 1956, who were followed up in the years 2001&ndash;2003 at age 46&ndash;51 with a postal questionnaire achieving a response rate of 64% (7183).</p>
</sec>
<sec><st>Outcome measures</st>
<p>Psychological distress at age 46&ndash;51 (questionnaire).</p>
</sec>
<sec><st>Results</st>
<p>Childhood intelligence and SES and education had indirect effects on psychological distress at midlife, mediated by adult SES. Adult SES was the only variable to have a significant direct effect on psychological distress at midlife; the effect was stronger in men than in women. Alternative measurement specifications of SES (reflective and formative) resulted in greatly different model parameters and fits.</p>
</sec>
<sec><st>Conclusions</st>
<p>Even though formative operationalisations of SES are theoretically appropriate, SES is better specified as reflective than as a formative latent variable in the context of life-course modelling.</p>
</sec>
]]></description>
<dc:creator><![CDATA[von Stumm, S., Deary, I. J., Hagger-Johnson, G.]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002772</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002772</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Research methods, Sociology]]></dc:subject>
<dc:title><![CDATA[Life-course pathways to psychological distress: a cohort study]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002772</prism:startingPage>
<prism:endingPage>e002772</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002819?rss=1">
<title><![CDATA[Social media use among patients and caregivers]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002819?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To map the state of the existing literature evaluating the use of social media in patient and caregiver populations.</p>
</sec>
<sec><st>Design</st>
<p>Scoping review.</p>
</sec>
<sec><st>Data sources</st>
<p>Medline, CENTRAL, ERIC, PubMed, CINAHL Plus Full Text, Academic Search Complete, Alt Health Watch, Health Source, Communication and Mass Media Complete, Web of Knowledge and ProQuest (2000&ndash;2012).</p>
</sec>
<sec><st>Study selection</st>
<p>Studies reporting primary research on the use of social media (collaborative projects, blogs/microblogs, content communities, social networking sites, virtual worlds) by patients or caregivers.</p>
</sec>
<sec><st>Data extraction</st>
<p>Two reviewers screened studies for eligibility; one reviewer extracted data from relevant studies and a second performed verification for accuracy and completeness on a 10% sample. Data were analysed to describe which social media tools are being used, by whom, for what purpose and how they are being evaluated.</p>
</sec>
<sec><st>Results</st>
<p>Two hundred eighty-four studies were included. Discussion forums were highly prevalent and constitute 66.6% of the sample. Social networking sites (14.8%) and blogs/microblogs (14.1%) were the next most commonly used tools. The intended purpose of the tool was to facilitate self-care in 77.1% of studies. While there were clusters of studies that focused on similar conditions (eg, lifestyle/weight loss (12.7%), cancer (11.3%)), there were no patterns in the objectives or tools used. A large proportion of the studies were descriptive (42.3%); however, there were also 48 (16.9%) randomised controlled trials (RCTs). Among the RCTs, 35.4% reported statistically significant results favouring the social media intervention being evaluated; however, 72.9% presented positive conclusions regarding the use of social media.</p>
</sec>
<sec><st>Conclusions</st>
<p>There is an extensive body of literature examining the use of social media in patient and caregiver populations. Much of this work is descriptive; however, with such widespread use, evaluations of effectiveness are required. In studies that have examined effectiveness, positive conclusions are often reported, despite non-significant findings.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hamm, M. P., Chisholm, A., Shulhan, J., Milne, A., Scott, S. D., Given, L. M., Hartling, L.]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002819</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002819</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Communication, Patient-centred medicine]]></dc:subject>
<dc:title><![CDATA[Social media use among patients and caregivers: a scoping review]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002819</prism:startingPage>
<prism:endingPage>e002819</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e001541corr1?rss=1">
<title><![CDATA[Correction]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e001541corr1?rss=1</link>
<description><![CDATA[
<sec id="s1">
<p>Langton DJ, Sidaginamale RP, Joyce TJ, <I>et al</I>. The clinical implications of elevated blood metal ion concentrations in asymptomatic patients with MoM hip resurfacings: a cohort study. <I>BMJ Open</I> 2013;<b>3</b>:<addart type="err" doi="10.1136/bmjopen-2012-001541">e001541</addart>.</p>
<p>The funding statement in this article should have been: &lsquo;This work was funded by a grant from the British Orthopaedic Association/Joint Action.&rsquo;</p>
<p>The competing interests statement should have been: DJL, is an unpaid consultant for Wright Medical; DJL, AVFN, SN and TJJ are expert witnesses in ongoing litigation regarding MoM hip joints; DJL has been reimbursed for individual talks for DePuy and Finsbury; AVFN has received reimbursement for DePuy educational sessions; AVFN and DJL have received reimbursement for travel to educational meetings by Smith and Nephew, Zimmer, DePuy and Wright Medical.'</p>
</sec>
]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-001541corr1</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-001541corr1</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[Correction]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Correction</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e001541corr1</prism:startingPage>
<prism:endingPage>e001541corr1</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002083corr1?rss=1">
<title><![CDATA[Correction]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002083corr1?rss=1</link>
<description><![CDATA[ <sec id="s1"> <p>Panaretto KS, Gardner KL, Button S, <I>et al.</I> Prevention and management of chronic disease in Aboriginal and Islander Community Controlled Health Services in Queensland: a quality improvement study assessing change in selected clinical performance indicators over time in a cohort of services. <I>BMJ Open</I> 2013;<b>3</b>:<addart type="err" doi="10.1136/bmjopen-2012-002083">e002083</addart>. An author, D Leon, was omitted from the paper in the original version. The order of authors was also incorrect. The correct list of authors is as follows:</p> <p>K S Panaretto,<sup>1</sup> K L Gardner,<sup>2</sup> S Button,<sup>1</sup> A Carson,<sup>3</sup> D Leon,<sup>1</sup> R Schibasaki,<sup>1</sup> G Wason,<sup>4</sup> D Baker,<sup>4</sup> J Mein,<sup>5</sup> A Dellit,<sup>1</sup> M Wenitong,<sup>5</sup> D Lewis,<sup>1</sup> I Ring<sup>6</sup></p> <p>As a result of this addition, the contributor statement has been revised:</p> <p><b>Contributors</b> AC, KSP, DL and DL led the development of the QAIHC Health information infrastructure. KSP, SB, DL and AC conceived the idea of the study and was responsible for study design....]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2013-05-09T23:22:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002083corr1</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002083corr1</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[Correction]]></dc:title>
<prism:publicationDate>2013-05-09</prism:publicationDate>
<prism:section>Correction</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002083corr1</prism:startingPage>
<prism:endingPage>e002083corr1</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002331?rss=1">
<title><![CDATA[Contact with a podiatrist and lower extremity amputation in people with diabetes]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002331?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine the effect of contact with a podiatrist on the occurrence of Lower Extremity Amputation (LEA) in people with diabetes.</p>
</sec>
<sec><st>Design and data sources</st>
<p>We conducted a systematic review of available literature on the effect of contact with a podiatrist on the risk of LEA in people with diabetes. Eligible studies, published in English, were identified through searches of PubMed, CINAHL, EMBASE and Cochrane databases. The key terms, &lsquo;podiatry&rsquo;, &lsquo;amputation&rsquo; and &lsquo;diabetes&rsquo;, were searched as Medical Subject Heading terms. Reference lists of selected papers were hand-searched for additional articles. No date restrictions were imposed.</p>
</sec>
<sec><st>Study selection</st>
<p>Published randomised and analytical observational studies of the effect of contact with a podiatrist on the risk of LEA in people with diabetes were included. Cross-sectional studies, review articles, chart reviews and case series were excluded. Two reviewers independently assessed titles, abstracts and full articles to identify eligible studies and extracted data related to the study design, characteristics of participants, interventions, outcomes, control for confounding factors and risk estimates.</p>
</sec>
<sec><st>Analysis</st>
<p>Meta-analysis was performed separately for randomised and non-randomised studies. Relative risks (RRs) with 95% CIs were estimated with fixed and random effects models as appropriate.</p>
</sec>
<sec><st>Results</st>
<p>Six studies met the inclusion criteria and five provided data included in meta-analysis. The identified studies were heterogenous in design and included people with diabetes at both low and high risk of amputation. Contact with a podiatrist did not significantly affect the RR of LEA in a meta-analysis of available data from randomised controlled trials (RCTs); (1.41, 95% CI 0.20 to 9.78, 2 RCTs) or from cohort studies; (0.73, 95% CI 0.39 to 1.33, 3 Cohort studies with four substudies in one cohort).</p>
</sec>
<sec><st>Conclusions</st>
<p>There are very limited data available on the effect of contact with a podiatrist on the risk of LEA in people with diabetes.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Buckley, C. M., Perry, I. J., Bradley, C. P., Kearney, P. M.]]></dc:creator>
<dc:date>2013-05-08T00:47:09-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002331</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002331</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Diabetes and endocrinology, Evidence based practice, Health services research, Surgery]]></dc:subject>
<dc:title><![CDATA[Does contact with a podiatrist prevent the occurrence of a lower extremity amputation in people with diabetes? A systematic review and meta-analysis]]></dc:title>
<prism:publicationDate>2013-05-08</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002331</prism:startingPage>
<prism:endingPage>e002331</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002497?rss=1">
<title><![CDATA[Subjective assessment of the duration of cataract surgery]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002497?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Surgery duration is a source of preoperative anxiety for patients undergoing cataract surgery. To better inform patients, we evaluated the agreement between objective and patient-perceived surgery durations.</p>
</sec>
<sec><st>Design</st>
<p>Case series.</p>
</sec>
<sec><st>Setting</st>
<p>Public teaching university hospital (Paris, France).</p>
</sec>
<sec><st>Participants</st>
<p>During the study period, 368 cataract surgery cases performed on 285 patients were included, 85 cases were excluded from the final analysis. All patients who had uneventful phacoemulsification were included. Cases with any significant intraoperative adverse event or cases requiring additional anaesthesia other than topical were excluded. Resident performed cases were also excluded.</p>
</sec>
<sec><st>Primary and secondary outcomes</st>
<p>Procedures were timed (objective duration) and patients were asked, immediately afterwards, to assess the duration of their surgery (patient-assessed duration). The agreement between objective and patient-assessed durations as well as influencing factors was studied.</p>
</sec>
<sec><st>Results</st>
<p>Mean objective duration (13.9&plusmn;5&nbsp;min) and patient-assessed duration (15.3&plusmn;6.9&nbsp;min) were significantly correlated (Spearman's r=0.452, p&lt;0.0001). Furthermore, Bland-Altman analysis and the intraclass correlation coefficient (0.341, 95% CI 0.23 to 0.44) were quite in agreement. On univariate analysis, senior-performed procedures were significantly shorter than those performed by juniors (13.4 vs 17.8&nbsp;min, p=0.0001). Pain was recorded as &lsquo;no sensation&rsquo; (31.5% of the cases), &lsquo;mild sensation&rsquo; (41%), &lsquo;moderate pain&rsquo; (23.3%), &lsquo;intense pain&rsquo; (3.5%) and &lsquo;unbearable pain&rsquo; (0.7%). Groups with high pain score had significantly longer procedures (p&lt;0.001). Multivariate analysis revealed that the only independent factors associated with both the objective and patient-assessed durations of surgery were surgeon's experience and pain-score.</p>
</sec>
<sec><st>Conclusions</st>
<p>In our study, patients&rsquo; estimated and real duration of the surgery showed moderate agreement, suggesting that emotions associated with eye surgery under topical anaesthesia did not dramatically hinder the patients&rsquo; perception of time. However, the benefit of preoperative counselling regarding the duration of surgery will need further evaluation.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Rothschild, P.-R., Grabar, S., Le Du, B., Temstet, C., Rostaqui, O., Brezin, A. P.]]></dc:creator>
<dc:date>2013-05-08T00:47:09-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002497</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002497</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Medical education and training, Ophthalmology, Patient-centred medicine, Surgery]]></dc:subject>
<dc:title><![CDATA[Patients' subjective assessment of the duration of cataract surgery: a case series]]></dc:title>
<prism:publicationDate>2013-05-08</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002497</prism:startingPage>
<prism:endingPage>e002497</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002538?rss=1">
<title><![CDATA[RCT of an education and support package for stroke]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002538?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Tailoring stroke information and providing reinforcement opportunities are two strategies proposed to enhance the effectiveness of education. This study aimed to evaluate the effects of an education package which utilised both strategies on the knowledge, health and psychosocial outcomes of stroke patients and carers.</p>
</sec>
<sec><st>Design</st>
<p>Multisite, randomised trial comparing usual care with an education and support package.</p>
</sec>
<sec><st>Setting</st>
<p>Two acute stroke units.</p>
</sec>
<sec><st>Participants</st>
<p>Patients and their carers (N=138) were randomised (control n=67, intervention n=71) of which data for 119 participants (control n=59, intervention n=60) were analysed.</p>
</sec>
<sec><st>Intervention</st>
<p>The package consisted of a computer-generated, tailored written information booklet and verbal reinforcement provided prior to, and for 3&nbsp;months following, discharge.</p>
</sec>
<sec><st>Outcome measures</st>
<p>Outcome measures were administered prior to hospital discharge and at 3-month follow-up by blinded assessors. The primary outcome was stroke knowledge (score range: 0&ndash;25). Secondary outcomes were: self-efficacy (1&ndash;10), anxiety and depression (0&ndash;21), ratings of importance of information (1&ndash;10), feelings of being informed (1&ndash;10), satisfaction with information (1&ndash;10), caregiver burden (carers) (0&ndash;13) and quality of life (patients) (1&ndash;5).</p>
</sec>
<sec><st>Results</st>
<p>Intervention group participants reported better: self-efficacy for accessing stroke information (adjusted mean difference (MD) of 1.0, 95% CI 0.3 to 1.7, p=0.004); feeling informed (MD 0.9, 95% CI 0.2 to 1.6, p=0.008); and satisfaction with medical (MD 2.0, 95% CI 1.1 to 2.8, p&lt;0.001); practical (MD 1.1, 95% CI 0.3 to 1.9, p=0.008), services and benefits (MD 0.9, 95% CI 0.1 to 1.8, p=0.036) and secondary prevention information (MD 1.7, 95% CI 0.9 to 2.5, p&lt;0.001). There was no significant effect on other outcomes.</p>
</sec>
<sec><st>Conclusions</st>
<p>Intervention group participants had improved self-efficacy for accessing stroke information and satisfaction with information, but other outcomes were not significantly affected. Evaluation of a more intensive intervention in a trial with a larger sample size is required to establish the value of an educational intervention that uses tailoring and reinforcement strategies.</p>
<p>ACTRN12608000469314</p>
</sec>
]]></description>
<dc:creator><![CDATA[Eames, S., Hoffmann, T., Worrall, L., Read, S., Wong, A.]]></dc:creator>
<dc:date>2013-05-08T00:47:09-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002538</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002538</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Neurology, Rehabilitation medicine]]></dc:subject>
<dc:title><![CDATA[Randomised controlled trial of an education and support package for stroke patients and their carers]]></dc:title>
<prism:publicationDate>2013-05-08</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002538</prism:startingPage>
<prism:endingPage>e002538</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002578?rss=1">
<title><![CDATA[Regional variation in current UK ophthalmic surgical training]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002578?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To evaluate surgical experience among current doctors appointed into ophthalmology training posts since the introduction of the Modernising Medical Careers programme. Additionally, to identify regional variations in surgical experience and training programme delivery.</p>
</sec>
<sec><st>Design</st>
<p>A cross-sectional survey.</p>
</sec>
<sec><st>Setting</st>
<p>The UK's four largest deaneries (Schools of Ophthalmology).</p>
</sec>
<sec><st>Participants</st>
<p>Trainee ophthalmologists, all having completed three or more years of training, who were appointed to the new ophthalmic specialty training programme.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>The mean annual surgical rate for each deanery in phacoemulsification cataract extractions and experience in other common elective and emergency surgical operations. Second, to calculate the mean timetabled clinical activity.</p>
</sec>
<sec><st>Results</st>
<p>The responses of 40 doctors were analysed, with a response rate of 83%. Overall, the phacoemulsification rate was 73.52&plusmn;29.24 operations/year. This was significantly higher in the South Thames Deanery (99.69&plusmn;26.16, p=0.0005) and significantly lower in the North Western Deanery (48.08&plusmn;19.72, p=0.0008). The annual mean complex cataract rate was 5.21&plusmn;4.38. Only 40% were confident in dealing with the most common complication of cataract surgery (vitreous loss). The mean trabeculectomy (surgery for glaucoma) rate was 0.47&plusmn;1.16 and for squint surgery it was 3.54&plusmn;2.82 operations/year. Regarding the common ocular trauma surgery, 42.5% had not sutured a corneal laceration and 60% a globe rupture. 50% thought the training programme would adequately prepare them surgically. The timetabled clinical activity was highest in the South Thames Deanery (48.17&nbsp;h/week) and lowest in the North Western Deanery (40.82&nbsp;h/week) due to variations in the European Working Time Directive implementation and on-call commitments.</p>
</sec>
<sec><st>Conclusions</st>
<p>Significant regional variations in surgical training experience exist between UK deaneries, particularly with respect to cataract surgery, and they appear to be correlated to timetabled activity. Experience and confidence levels in managing complex cataract surgery and complications were low and experience with previously commonly performed elective and emergency operations was minimal. Although doctors from all the regions surveyed were very likely to achieve the minimum cataract extractions required for specialist training completion, we have identified shortcomings of the current training programme that need attention.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Rodrigues, I. A., Symes, R. J., Turner, S., Sinha, A., Bowler, G., Chan, W. H.]]></dc:creator>
<dc:date>2013-05-06T17:05:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002578</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002578</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Medical education and training, Ophthalmology, Surgery]]></dc:subject>
<dc:title><![CDATA[Ophthalmic surgical training following modernising medical careers: regional variation in experience across the UK]]></dc:title>
<prism:publicationDate>2013-05-06</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002578</prism:startingPage>
<prism:endingPage>e002578</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002067?rss=1">
<title><![CDATA[Attitudes to visual field test intervals]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002067?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To establish the attitudes of glaucoma specialists to the frequency of visual field (VF) testing in the UK, using the NICE recommendations as a standard for ideal practice.</p>
</sec>
<sec><st>Design</st>
<p>Interview and postal survey.</p>
</sec>
<sec><st>Setting</st>
<p>UK and Eire Glaucoma Society national meeting 2011 in Manchester, UK, with a second round of surveys administered by post.</p>
</sec>
<sec><st>Participants</st>
<p>All consultant glaucoma specialists in England and Wales were invited to complete the survey.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>(1) Compliance of assigned follow-up VF intervals with NICE guidelines for three hypothetical patient scenarios, with satisfactory treated intraocular pressure and (a) no evidence of VF progression; (b) evidence of VF progression and (c) uncertainty about VF progression, and respondents were asked to provide typical follow-up intervals representative of their practice; (2) attitudes to research recommendations for six VF in the first 2&nbsp;years for newly diagnosed patients with glaucoma.</p>
</sec>
<sec><st>Results</st>
<p>70 glaucoma specialists completed the survey. For each of the clinical scenarios a, b and c, 14 (20%), 33 (47%) and 28 (40%) responses, respectively, fell outside the follow-up interval recommended by NICE. Nearly half of the specialists (46%) agreed that 6 VF tests in the first 2&nbsp;years was ideal practice, while 16 (28%) said this was practice &lsquo;not possible&rsquo;, with many giving resources within the NHS setting as a limiting factor.</p>
</sec>
<sec><st>Conclusions</st>
<p>The results from this survey suggest that there is a large variation in attitudes to follow-up intervals for patients with glaucoma in the UK, with assigned intervals for VF testing which are, in many cases, inconsistent with the guidelines from NICE.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Malik, R., Baker, H., Russell, R. A., Crabb, D. P.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002067</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002067</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Health services research, Ophthalmology]]></dc:subject>
<dc:title><![CDATA[A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002067</prism:startingPage>
<prism:endingPage>e002067</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002224?rss=1">
<title><![CDATA[Scoping study on access to medicines]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002224?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To assess scientific publication and map research gaps on access to medicines (ATM) in Latin American and the Caribbean low-income and middle-income countries (LMIC).</p>
</sec>
<sec><st>Design</st>
<p>Scoping review. Two independent reviewers assessed studies for inclusion and extracted data from each study.</p>
</sec>
<sec><st>Information sources</st>
<p>Search strategies were developed and the following databases were searched: MEDLINE, ISI, SCOPUS and Lilacs, from 2000 to 2010.</p>
</sec>
<sec><st>Eligibility criteria</st>
<p>Research articles and reviews published in English, Spanish and Portuguese were included. Studies including only high-income countries were excluded, as well as those carried out in very limited settings and discussion papers.</p>
</sec>
<sec><st>Results</st>
<p>The 77 articles retained were categorised through consensus among the research team according to the level of the health system addressed, ATM domain and research issues covered. Publications on ATM have increased over time during the study period (r 0.93, p=0.00; R<sup>2</sup> 0.85). The top five countries covered were Brazil (68.8%), Mexico (15.6%), Colombia (11.7%), Argentina (10.4%) and Peru (10.4%). &lsquo;Health services delivery&rsquo; and &lsquo;patients, household and communities&rsquo; were the health system levels most frequently covered. The ATM domains &lsquo;leadership and governance&rsquo;, &lsquo;sustainable financing, affordability and price of medicines&rsquo;, &lsquo;medicines selection and use&rsquo; and &lsquo;availability of medicines&rsquo; were the top four explored. There are research gaps in important areas such as &lsquo;human resources for health&rsquo;, &lsquo;global policies and human rights&rsquo;, &lsquo;production of medicines&rsquo; and &lsquo;traditional medicine&rsquo;.</p>
</sec>
<sec><st>Conclusions</st>
<p>The upward trend on scientific publication reflects a growing research capacity in the region, which is concentrated on research teams in selected countries. The gaps on research capacity could be overcome through research collaboration among countries. It is important to strengthen these collaborations, assuring that interests and needs from the LMIC are addressed and local capacity building is promoted.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Emmerick, I. C. M., Oliveira, M. A., Luiza, V. L., Azeredo, T. B., Bigdeli, M.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002224</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002224</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Global health, Health economics, Health policy, Pharmacology and therapeutics, Research methods]]></dc:subject>
<dc:title><![CDATA[Access to medicines in Latin America and the Caribbean (LAC): a scoping study]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002224</prism:startingPage>
<prism:endingPage>e002224</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002378?rss=1">
<title><![CDATA[Irrational differences in drug utilisation between men and women?]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002378?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Ascertain the extent of differences between men and women in dispensed drugs since there is a lack of comprehensive overviews on sex differences in the use of prescription drugs.</p>
</sec>
<sec><st>Design</st>
<p>Cross-sectional population database analysis.</p>
</sec>
<sec><st>Methods</st>
<p>Data on all dispensed drugs in 2010 to the entire Swedish population (9.3 million inhabitants) were obtained from the Swedish Prescribed Drug Register. All pharmacological groups with ambulatory care prescribing accounting for &gt;75% of the total volume in Defined Daily Doses and a prevalence of &gt;1% were included in the analysis. Crude and age-adjusted differences in prevalence and incidence were calculated as risk ratios (RRs) of women/men.</p>
</sec>
<sec><st>Results</st>
<p>In all, 2.8 million men (59%) and 3.6 million women (76%) were dispensed at least one prescribed drug during 2010. Women were dispensed more drugs in all age groups except among children under the age of 10. The largest sex difference in prevalence in absolute numbers was found for antibiotics that were more common in women, 265.5 patients (PAT)/1000 women and 191.3 PAT/1000 men, respectively. This was followed by thyroid therapy (65.7 PAT/1000 women and 13.1 PAT/1000 men) and antidepressants (106.6 PAT/1000 women and 55.4 PAT/1000 men). Age-adjusted relative sex differences in prevalence were found in 48 of the 50 identified pharmacological groups. The pharmacological groups with the largest relative differences of dispensed drugs were systemic antimycotics (RR 6.6 CI 6.4 to 6.7), drugs for osteoporosis (RR 4.9 CI 4.9 to 5.0) and thyroid therapy (RR 4.5 CI 4.4 to 4.5), which were dispensed to women to a higher degree. Antigout agents (RR 0.4 CI 0.4 to 0.4), psychostimulants (RR 0.6 CI 0.6 to 0.6) and ACE inhibitors (RR 0.7 CI 0.7 to 0.7) were dispensed to men to a larger proportion.</p>
</sec>
<sec><st>Conclusions</st>
<p>Substantial differences in the prevalence and incidence of dispensed drugs were found between men and women. Some differences may be rational and desirable and related to differences between the sexes in the incidence or prevalence of disease or by biological differences. Other differences are more difficult to explain on medical grounds and may indicate unequal treatment.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Loikas, D., Wettermark, B., von Euler, M., Bergman, U., Schenck-Gustafsson, K.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002378</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002378</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Cardiovascular medicine, Infectious diseases, Medical management, Pharmacology and therapeutics, Public health]]></dc:subject>
<dc:title><![CDATA[Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002378</prism:startingPage>
<prism:endingPage>e002378</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002399?rss=1">
<title><![CDATA[Living with HIV postdiagnosis: a qualitative study from Nairobi slums]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002399?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To characterise the experiences of heterosexual men and women living with HIV postdiagnosis and explain these experiences in relation to their identity and sexuality.</p>
</sec>
<sec><st>Design</st>
<p>Qualitative study using in-depth interviews and a theoretically informed biographic disruption theory.</p>
</sec>
<sec><st>Setting</st>
<p>Interviews were conducted in two Nairobi slums (Kenya).</p>
</sec>
<sec><st>Participants</st>
<p>41 HIV-infected heterosexual men and women aged 18&nbsp;years or older.</p>
</sec>
<sec><st>Results</st>
<p>People living with HIV have divergent experiences surrounding HIV diagnosis. Postdiagnosis, there are multiple phases of identity transition, including status (non-)disclosure, and attempts at identity repair and normalcy. For some people, this process involves a transition to a new self-identity, incorporating both HIV and antiretroviral treatment (ART) into their lives. For others, it involves a partial transition, with some aspects of their prediagnosis identity persisting, and for others it involves a rejection of HIV identity. Those people who were able to incorporate HIV/AIDS in their identity, without it being disruptive to their biography, were pursuing safer sexual and reproductive lives. By contrast, those people with a more continuous biography continued to reflect their prediagnosis identity and sexual behaviour.</p>
</sec>
<sec><st>Conclusions</st>
<p>People living with HIV/AIDS (PLWHA) had to rework their sense of identity following diagnosis in the context of living in a slum setting. Men and women living with HIV in slums are poorly supported by health systems and services as they attempt to cope with a diagnosis of HIV. Given the availability of ART, health services and professionals need to support the rights of PLWHA to be sexually active if they want to and achieve their fertility goals, while minimising HIV transmission risk.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Wekesa, E., Coast, E.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002399</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002399</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Qualitative research, HIV AIDS]]></dc:subject>
<dc:title><![CDATA[Living with HIV postdiagnosis: a qualitative study of the experiences of Nairobi slum residents]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002399</prism:startingPage>
<prism:endingPage>e002399</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002413?rss=1">
<title><![CDATA[Overactive bladder and falls]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002413?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To examine the association between overactive bladder (OAB) symptom severity and falls and the contribution of OAB symptoms to falls in a community-dwelling population.</p>
</sec>
<sec><st>Design</st>
<p>Cross-sectional study.</p>
</sec>
<sec><st>Setting</st>
<p>2 Japanese municipalities.</p>
</sec>
<sec><st>Participants</st>
<p>A total of 2505 residents aged over 40&nbsp;years, who participated in health check-ups conducted in 2010. OAB symptom assessed via overactive bladder symptom score (OABSS) was divided into six categories based on distribution and Japanese clinical guidelines. Mobility problems and depressive symptoms were assessed via the Timed Up and Go test and the short form of the Center for Epidemiologic Studies Depression Scale, respectively.</p>
</sec>
<sec><st>Primary outcome measures</st>
<p>Self-reported any fall and frequent fall (&ge;2) over the 1-month period. Independent contributions to any fall and frequent falls were assessed via logistic regression to generate population-attributable fractions (PAFs), assuming separate causal relationships between OAB symptoms, mobility problems and depressive symptoms and any or frequent falls.</p>
</sec>
<sec><st>Results</st>
<p>Among the total 1350 participants (mean age: 68.3&nbsp;years) analysed, any fall and frequent falls were reported by 12.7% and 4.4%, respectively. Compared with no OABSS score, moderate-to-severe OAB and mild OAB were associated with any fall (adjusted ORs 2.37 (95% CI 1.12 to 4.98) and 2.51 (95% CI 1.14 to 5.52), respectively). Moderate-to-severe OAB was also strongly associated with frequent falls (adjusted OR 6.90 (95% CI 1.50 to 31.6)). Adjusted PAFs of OAB symptoms were 40.7% (95% CI 0.7% to 64.6%) for any fall and 67.7% (95% CI &ndash;23.1% to 91.5%) for frequent falls. Further, these point estimates were similar to or larger than those of mobility problems and depressive symptoms.</p>
</sec>
<sec><st>Conclusions</st>
<p>An association does indeed exist between OAB symptom severity and falls, and OAB symptoms might be important contributors to falls among community-dwelling adults. Further longitudinal studies are warranted to examine whether or not OAB symptoms predict risk of future falls and fall-related injuries.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Kurita, N., Yamazaki, S., Fukumori, N., Otoshi, K., Otani, K., Sekiguchi, M., Onishi, Y., Takegami, M., Ono, R., Horie, S., Konno, S.-i., Kikuchi, S.-i., Fukuhara, S.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002413</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002413</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Public health, Urology]]></dc:subject>
<dc:title><![CDATA[Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002413</prism:startingPage>
<prism:endingPage>e002413</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002540?rss=1">
<title><![CDATA[Nodding syndrome in Ugandan children]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002540?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Nodding syndrome is a devastating neurological disorder of uncertain aetiology affecting children in Africa. There is no diagnostic test, and risk factors and symptoms that would allow early diagnosis are poorly documented. This study aimed to describe the clinical, electrophysiological and brain imaging (MRI) features and complications of nodding syndrome in Ugandan children.</p>
</sec>
<sec><st>Design</st>
<p>Case series.</p>
</sec>
<sec><st>Participants</st>
<p>22 children with nodding syndrome brought to Mulago National Referral Hospital for assessment.</p>
</sec>
<sec><st>Outcome measures</st>
<p>Clinical features, physical and functional disabilities, EEG and brain MRI findings and a staging system with a progressive development of symptoms and complications.</p>
</sec>
<sec><st>Results</st>
<p>The median age of symptom onset was 6 (range 4&ndash;10) years and median duration of symptoms was 8.5 (range 2&ndash;11) years. 16 of 22 families reported multiple affected children. Physical manifestations and complications included stunting, wasting, lip changes and gross physical deformities. The bone age was delayed by 2 (range 1&ndash;6) years. There was peripheral muscle wasting and progressive generalised wasting. Four children had nodding as the only seizure type; 18 in addition had myoclonic, absence and/or generalised tonic&ndash;clonic seizures developing 1&ndash;3&nbsp;years after the onset of illness. Psychiatric manifestations included wandering, aggression, depression and disordered perception. Cognitive assessment in three children demonstrated profound impairment. The EEG was abnormal in all, suggesting symptomatic generalised epilepsy in the majority. There were different degrees of cortical and cerebellar atrophy on brain MRI, but no hippocampal changes. Five stages with worsening physical, EEG and brain imaging features were identified: a prodrome, the development of head nodding and cognitive decline, other seizure types, multiple complications and severe disability.</p>
</sec>
<sec><st>Conclusions</st>
<p>Nodding syndrome is a neurological disorder that may be characterised as probably symptomatic generalised epilepsy. Clinical manifestations and complications develop in stages which might be useful in defining treatment and rehabilitation. Studies of risk factors, pathogenesis, management and outcome are urgently needed.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Idro, R., Opoka, R. O., Aanyu, H. T., Kakooza-Mwesige, A., Piloya-Were, T., Namusoke, H., Musoke, S. B., Nalugya, J., Bangirana, P., Mwaka, A. D., White, S., Chong, K., Atai-Omoruto, A. D., Mworozi, E., Nankunda, J., Kiguli, S., Aceng, J. R., Tumwine, J. K.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002540</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002540</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Neurology, Paediatrics]]></dc:subject>
<dc:title><![CDATA[Nodding syndrome in Ugandan children--clinical features, brain imaging and complications: a case series]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002540</prism:startingPage>
<prism:endingPage>e002540</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002607?rss=1">
<title><![CDATA[The MEND 5-7 programme]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002607?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The aim of this study was to report outcomes of the UK service level delivery of MEND (Mind,Exercise,Nutrition...Do it!) 5-7, a multicomponent, community-based, healthy lifestyle intervention designed for overweight and obese children aged 5&ndash;7&nbsp;years and their families.</p>
</sec>
<sec><st>Design</st>
<p>Repeated measures.</p>
</sec>
<sec><st>Setting</st>
<p>Community venues at 37 locations across the UK.</p>
</sec>
<sec><st>Participants</st>
<p>440 overweight or obese children (42% boys; mean age 6.1&nbsp;years; body mass index (BMI) z-score 2.86) and their parents/carers participated in the intervention.</p>
</sec>
<sec><st>Intervention</st>
<p>MEND 5-7 is a 10-week, family-based, child weight-management intervention consisting of weekly group sessions. It includes positive parenting, active play, nutrition education and behaviour change strategies. The intervention is designed to be scalable and delivered by a range of health and social care professionals.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>The primary outcome was BMI z-score. Secondary outcome measures included BMI, waist circumference, waist circumference z-score, children's psychological symptoms, parenting self-efficacy, physical activity and sedentary behaviours and the proportion of parents and children eating five or more portions of fruit and vegetables.</p>
</sec>
<sec><st>Results</st>
<p>274 (62%) children were measured preintervention and post-intervention (baseline; 10-weeks). Post-intervention, mean BMI and waist circumference decreased by 0.5&nbsp;kg/m<sup>2</sup> and 0.9&nbsp;cm, while z-scores decreased by 0.20 and 0.20, respectively (p&lt;0.0001). Improvements were found in children's psychological symptoms (&ndash;1.6 units, p&lt;0.0001), parent self-efficacy (p&lt;0.0001), physical activity (+2.9&nbsp;h/week, p&lt;0.01), sedentary activities (&ndash;4.1&nbsp;h/week, p&lt;0.0001) and the proportion of parents and children eating five or more portions of fruit and vegetables per day (both p&lt;0.0001). Attendance at the 10 sessions was 73% with a 70% retention rate.</p>
</sec>
<sec><st>Conclusions</st>
<p>Participation in the MEND 5-7 programme was associated with beneficial changes in physical, behavioural and psychological outcomes for children with complete sets of measurement data, when implemented in UK community settings under service level conditions. Further investigation is warranted to establish if these findings are replicable under controlled conditions.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Smith, L. R., Chadwick, P., Radley, D., Kolotourou, M., Gammon, C. S., Rosborough, J., Sacher, P. M.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002607</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002607</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Nutrition and metabolism, Paediatrics, Public health]]></dc:subject>
<dc:title><![CDATA[Assessing the short-term outcomes of a community-based intervention for overweight and obese children: The MEND 5-7 programme]]></dc:title>
<prism:publicationDate>2013-05-14</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002607</prism:startingPage>
<prism:endingPage>e002607</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002758?rss=1">
<title><![CDATA[Dabigatran use in AF patients]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002758?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse.</p>
</sec>
<sec><st>Design</st>
<p>Pharmacoepidemiological cohort study.</p>
</sec>
<sec><st>Methods/settings</st>
<p>From nationwide registers, we identified patients with an in-hospital or outpatient-clinic AF diagnosis who claimed a prescription of dabigatran 110 or 150&nbsp;mg, or vitamin K antagonist (VKA), between 22 August and 31 December 2011. HRs of thromboembolic events (ischaemic stroke, transitory ischaemic attack and peripheral artery embolism) and bleedings were estimated using Cox regression analyses in all patients and stratified by previous VKA use.</p>
</sec>
<sec><st>Results</st>
<p>Overall, 1612 (3.1%) and 1114 (2.1%) patients claimed a prescription of dabigatran 110 and 150&nbsp;mg, and 49640 (94.8%) of VKA. Patients treated with dabigatran 150&nbsp;mg were younger with less comorbidity than those treated with dabigatran 110&nbsp;mg and VKA, as were VKA na&iuml;ve patients compared with previous VKA users. Recommendations set by the European Medicine Agency (EMA) for dabigatran were met in 90.3% and 55.5% of patients treated with 110 and 150&nbsp;mg. Patients treated with 150&nbsp;mg dabigatran, who did not fulfil the recommendations by EMA, were &gt;80&nbsp;years, patients with liver or kidney disease, patients with previous bleeding. Compared with VKA, the thromboembolic risk associated with dabigatran 110 and 150&nbsp;mg was HR 3.52 (1.40 to 8.84) and 5.79 (1.81 to 18.56) in previous VKA users, and HR 0.95(0.47 to 1.91) and 1.14(0.60 to 2.16) in VKA na&iuml;ve patients. Bleeding risk was increased in previous VKA users receiving dabigatran 110&nbsp;mg, but not in patients with 150&nbsp;mg dabigatran, nor in the VKA na&iuml;ve users.</p>
</sec>
<sec><st>Conclusions</st>
<p>Deviations from the recommended use of dabigatran were frequent among patients treated with 150&nbsp;mg. With cautious interpretation, dabigatran use in VKA na&iuml;ve patients seems safe. Increased risk of thromboembolism and bleeding with dabigatran among previous VKA users was unexpected and may reflect patient selection and &lsquo;drug switching&rsquo; practices.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Sorensen, R., Gislason, G., Torp-Pedersen, C., Olesen, J. B., Fosbol, E. L., Hvidtfeldt, M. W., Karasoy, D., Lamberts, M., Charlot, M., Kober, L., Weeke, P., Lip, G. Y. H., Hansen, M. L.]]></dc:creator>
<dc:date>2013-05-03T20:44:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002758</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002758</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Cardiovascular medicine, Pharmacology and therapeutics]]></dc:subject>
<dc:title><![CDATA[Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study]]></dc:title>
<prism:publicationDate>2013-05-03</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002758</prism:startingPage>
<prism:endingPage>e002758</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002521?rss=1">
<title><![CDATA[Publication rate for funded studies from a major UK health research funder]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002521?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>This study aimed to investigate what percentage of National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme-funded projects have published their final reports in the programme's journal HTA and to explore reasons for non-publication.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective cohort study.</p>
</sec>
<sec><st>Setting</st>
<p>Failure to publish findings from research is a significant area of research waste. It has previously been suggested that potentially over 50% of studies funded are never published.</p>
</sec>
<sec><st>Participants</st>
<p>All NIHR HTA projects with a planned submission date for their final report for publication in the journal series on or before 9 December 2011 were included.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>The projects were classified according to the type of research, whether they had been published or not; if not yet published, whether they would be published in the future or not. The reasons for non-publication were investigated.</p>
</sec>
<sec><st>Results</st>
<p>628 projects were included: 582 (92.7%) had published a monograph; 19 (3%) were expected to publish a monograph; 13 (2.1%) were discontinued studies and would not publish; 12 (1.9%) submitted a report which did not lead to a publication as a monograph; and two (0.3%) did not submit a report. Overall, 95.7% of HTA studies either have published or will publish a monograph: 94% for those commissioned in 2002 or before and 98% for those commissioned after 2002. Of the 27 projects for which there will be no report, the majority (21) were commissioned in 2002 or before. Reasons why projects failed to complete included failure to recruit; issues concerning the organisation where the research was taking place; drug licensing issues; staffing issues; and access to data.</p>
</sec>
<sec><st>Conclusions</st>
<p>The percentage of HTA projects for which a monograph is published is high. The advantages of funding organisations requiring publication in their own journal include avoidance of publication bias and research waste.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Turner, S., Wright, D., Maeso, R., Cook, A., Milne, R.]]></dc:creator>
<dc:date>2013-05-02T22:10:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002521</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002521</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Medical publishing and peer review]]></dc:subject>
<dc:title><![CDATA[Publication rate for funded studies from a major UK health research funder: a cohort study]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002521</prism:startingPage>
<prism:endingPage>e002521</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002604?rss=1">
<title><![CDATA[Influenza-like illness and acute myocardial infarction]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002604?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To investigate recent respiratory and influenza-like illnesses (ILIs) in acute myocardial infarction patients compared with patients hospitalised for acute non-vascular surgical conditions during the second wave of the 2009 influenza A H1N1 pandemic.</p>
</sec>
<sec><st>Design</st>
<p>Case&ndash;control study.</p>
</sec>
<sec><st>Setting</st>
<p>Coronary care unit, acute cardiology and acute surgical admission wards in a major teaching hospital in London, UK.</p>
</sec>
<sec><st>Participants</st>
<p>134 participants (70 cases and 64 controls) aged &ge;40&nbsp;years hospitalised for acute myocardial infarction and acute surgical conditions between 21 September 2009 and 28 February 2010, frequency-matched for gender, 5-year age-band and admission week.</p>
</sec>
<sec><st>Primary exposure</st>
<p>ILI (defined as feeling feverish with either a cough or sore throat) within the last month.</p>
</sec>
<sec><st>Secondary exposures</st>
<p>Acute respiratory illness within the last month not meeting ILI criteria; nasopharyngeal and throat swab positive for influenza virus.</p>
</sec>
<sec><st>Results</st>
<p>29 of 134 (21.6%) participants reported respiratory illness within the last month, of whom 13 (9.7%) had illnesses meeting ILI criteria. The most frequently reported category for timing of respiratory symptom onset was 8&ndash;14&nbsp;days before admission (31% of illnesses). Cases were more likely than controls to report ILI&mdash;adjusted OR 3.17 (95% CI 0.61 to 16.47)&mdash;as well as other key respiratory symptoms, and were less likely to have received influenza vaccination&mdash;adjusted OR 0.46 (95% CI 0.19 to 1.12)&mdash;although the differences were not statistically significant. No swabs were positive for influenza virus.</p>
</sec>
<sec><st>Conclusions</st>
<p>Point estimates suggested that recent ILI was more common in patients hospitalised with acute myocardial infarction than with acute surgical conditions during the second wave of the influenza A H1N1 pandemic, and influenza vaccination was associated with cardioprotection, although the findings were not statistically significant. The study was underpowered, partly because the age groups typically affected by acute myocardial infarction had low rates of infection with the pandemic influenza strain compared with seasonal influenza.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Warren-Gash, C., Geretti, A. M., Hamilton, G., Rakhit, R. D., Smeeth, L., Hayward, A. C.]]></dc:creator>
<dc:date>2013-05-02T22:10:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002604</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002604</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Cardiovascular medicine, Epidemiology, Infectious diseases]]></dc:subject>
<dc:title><![CDATA[Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case-control study]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002604</prism:startingPage>
<prism:endingPage>e002604</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002640?rss=1">
<title><![CDATA[Comparison of health confidence in the UK and the USA]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002640?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Confidence in healthcare may influence the patients&rsquo; utilisation of healthcare resources and perceptions of healthcare quality. We sought to determine whether self-reported confidence in healthcare differed between the UK and the USA, as well as by rurality or urbanicity.</p>
</sec>
<sec><st>Design</st>
<p>A secondary analysis of a subset of survey questions regarding self-reported confidence in healthcare from the 2010 Commonwealth Fund International Health Policy Survey.</p>
</sec>
<sec><st>Setting</st>
<p>Telephone survey of participants from the UK and the USA.</p>
</sec>
<sec><st>Participants</st>
<p>Our final analysis included 1511 UK residents (688 rural, 446 suburban, 372 urban, 5 uncategorised) and 2501 US residents (536 rural, 1294 suburban, 671 urban).</p>
</sec>
<sec><st>Outcome measures</st>
<p>Questions assessed respondents&rsquo; confidence in the effectiveness and affordability of the treatment. We compared survey outcomes from these questions between, and within, the two regions and among, and within, residence types (rural, suburban and urban).</p>
</sec>
<sec><st>Results</st>
<p>Significant differences were found in self-reported confidence in healthcare between the UK and US, among residence types, and between the two regions within residence types. Reported levels were higher in the UK. Within regions, significant differences by residence type were found for the US, but not the UK. Within the US, suburban respondents had the highest self-reported confidence in healthcare.</p>
</sec>
<sec><st>Conclusions</st>
<p>Significant differences exist between the UK and US in confidence in healthcare. In the US, but not in the UK, self-reported confidence is related to residence type. Within countries, significant differences by residence type were found for the US, but not the UK. Our findings warrant the examination of causes for relative confidence levels in healthcare between regions and among US residence types.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Haven, K., Celaya, M. F., Pierson, J., Weisskopf, A. J., MacKinnon, N. J.]]></dc:creator>
<dc:date>2013-05-02T22:10:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002640</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002640</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Health policy, Health services research, Patient-centred medicine, Public health]]></dc:subject>
<dc:title><![CDATA[Comparison of health confidence in rural, suburban and urban areas in the UK and the USA: a secondary analysis]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002640</prism:startingPage>
<prism:endingPage>e002640</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002713?rss=1">
<title><![CDATA[Ethnicity, neighbourhood and mental health]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002713?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>A frequently proposed, but under-researched hypothesis is that ethnic density benefits mental health through increasing social interactions. We examined this hypothesis in 226&nbsp;487 adults from 19 ethnic groups aged 45&nbsp;years and older in Australia.</p>
</sec>
<sec><st>Methods</st>
<p>Multilevel logit regression was used to measure the association between ethnicity, social interactions, own-group ethnic density and scores of 22+ on the Kessler scale of psychological distress. Self-reported ancestry was used as a proxy for ethnicity. Measures of social interactions included a number of times in the past week were (i) spent with friends or family participants did not live with; (ii) talked to someone on the telephone; (iii) attended meetings of social groups and (iv) how many people could be relied upon outside their home, but within 1&nbsp;h of travel. Per cent own-group ethnic density was measured at the Census Collection District scale.</p>
</sec>
<sec><st>Results</st>
<p>Psychological distress was reported by 11% of Australians born in Australia. The risk of experiencing psychological distress varied among ethnic minorities and by country of birth (eg, 33% for the Lebanese born in Lebanon and 4% for the Swiss born in Switzerland). These differences remained after full adjustment. Social interactions varied between ethnic groups and were associated with lower psychological distress and ethnic density. Ethnic density was associated with reduced psychological distress for some groups. This association, however, was explained by individual and neighbourhood characteristics and not by social interactions.</p>
</sec>
<sec><st>Conclusions</st>
<p>Social interactions are important correlates of mental health, but fully explain neither the ethnic differences in psychological distress nor the protective effect of own-group density.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Feng, X., Astell-Burt, T., Kolt, G. S.]]></dc:creator>
<dc:date>2013-05-02T22:10:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002713</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002713</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Epidemiology, Mental health, Public health, Sociology]]></dc:subject>
<dc:title><![CDATA[Do social interactions explain ethnic differences in psychological distress and the protective effect of local ethnic density? A cross-sectional study of 226 487 adults in Australia]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002713</prism:startingPage>
<prism:endingPage>e002713</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002789?rss=1">
<title><![CDATA[Role of private health insurance in the rising caesarean section rate]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002789?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The caesarean section rates have been rising in the developed world for over two decades. This study assessed the involvement of the public and private health sectors in this increase.</p>
</sec>
<sec><st>Design</st>
<p>Population-based, retrospective cohort study.</p>
</sec>
<sec><st>Setting</st>
<p>Public and private hospitals in Western Australia.</p>
</sec>
<sec><st>Participants</st>
<p>Included in this study were 155&nbsp;646 births to nulliparous women during 1996&ndash;2008.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Caesarean section rates were calculated separately for four patient type groups defined according to mothers&rsquo; funding source at the time of birth (public/private) and type of delivery hospital (public/private). The average annual per cent change (AAPC) for the caesarean section rates was calculated using joinpoint regression.</p>
</sec>
<sec><st>Results</st>
<p>Overall, there were 45&nbsp;903 caesarean sections performed (29%) during the study period, 24&nbsp;803 in-labour and 21&nbsp;100 prelabour. Until 2005, the rate of caesarean deliveries increased most rapidly on average annually for private patients delivering in private hospitals (AAPC=6.5%) compared with public patients in public hospitals (AAPC=4.3%, p&lt;0.0001). This increase could mostly be attributed to an increase in prelabour caesarean deliveries for this group of women and could not be explained by an increase in breech deliveries, placenta praevia or multiple pregnancies.</p>
</sec>
<sec><st>Conclusions</st>
<p>Our results indicate that an increase in the prelabour caesarean delivery rate for private patients in private hospitals has been driving the increase in the caesarean section rate for nulliparous women since 1996. Future research with more detailed information on indication for the prelabour caesarean section is needed to understand the reasons for these findings.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Einarsdottir, K., Haggar, F., Pereira, G., Leonard, H., de Klerk, N., Stanley, F. J., Stock, S.]]></dc:creator>
<dc:date>2013-05-02T22:10:04-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2013-002789</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2013-002789</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Health services research, Obgyn]]></dc:subject>
<dc:title><![CDATA[Role of public and private funding in the rising caesarean section rate: a cohort study]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002789</prism:startingPage>
<prism:endingPage>e002789</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e001336?rss=1">
<title><![CDATA[BMI and esophagectomy]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e001336?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Given the increasing rate of obesity, the effects of excessive body weight on surgical outcomes constitute a relevant quality of care concern. Our aim was to determine the relationship between preoperative body mass index (BMI) on perioperative complications after oesophagectomy for adenocarcinoma of the oesophagus.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective database review.</p>
</sec>
<sec><st>Setting</st>
<p>Single institution high volume oncological tertiary care referral centre.</p>
</sec>
<sec><st>Participants</st>
<p>From our comprehensive oesophageal cancer database consisting of 709 patients, we stratified patients according to BMI: 155 normal-weight (BMI 20&ndash;24), 198 overweight (BMI 25&ndash;29) and 187 obese (BMI &ge;30) patients.</p>
</sec>
<sec><st>Interventions</st>
<p>All patients underwent oesophagectomy for cancer.</p>
</sec>
<sec><st>Primary and secondary outcome measures</st>
<p>Incidences of preoperative risk factors and perioperative complications in each group were analysed.</p>
</sec>
<sec><st>Results</st>
<p>The patient cohort consisted of 474 men and 66 women with a mean age of 64.3&nbsp;years (28&ndash;86). They were similar in terms of demographics and comorbidities, with the exception of a younger age (65.2 vs 65.4 vs 62.5&nbsp;years, p=0.0094), and a higher incidence of diabetes (9.1% vs 13.2% vs 22.7%, p=0.001), hiatal hernia (16.8% vs 17.8% vs 28.8%, p=0.009) and Barrett oesophagus (24.7% vs 25.4% vs 36.2%, p=0.025) for obese patients. The type of surgery performed, overall blood loss, extent of lymphadenectomy, R0 resections and complications were not influenced by BMI on univariate and multivariate analysis.</p>
</sec>
<sec><st>Conclusions</st>
<p>In our experience, patients with an elevated BMI and oesophageal adenocarcinoma do not experience an increase in morbidity and mortality after oesophagectomy as stated in previous reports, when performed at a high volume centre. Additionally, BMI did not affect the quality of oncological resection as determined by number of harvested lymph-nodes and rates of R0 resections.</p>
</sec>
<sec><st>Trial Registration</st>
<p>MCC 15030, IRB 105286.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Melis, M., Weber, J., Shridhar, R., Hoffe, S., Almhanna, K., Karl, R. C., Meredith, K. L.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-001336</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-001336</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Gastroenterology and hepatology, Oncology, Surgery]]></dc:subject>
<dc:title><![CDATA[Body mass index and perioperative complications after oesophagectomy for adenocarcinoma: a systematic database review]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e001336</prism:startingPage>
<prism:endingPage>e001336</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002154?rss=1">
<title><![CDATA[Systematic review of observational studies of red blood cell transfusion]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002154?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To carry out a systematic review of recently published large-scale observational studies assessing the effects of red blood cell transfusion (RBCT) on mortality, with particular emphasis on the statistical methods used to adjust for confounding. Given the limited number of randomised trials of the efficacy of RBCT, clinicians often use evidence from observational studies. However, confounding factors, for example, individuals receiving blood generally being sicker than those who do not, make their interpretation challenging.</p>
</sec>
<sec><st>Design</st>
<p>Systematic review.</p>
</sec>
<sec><st>Information sources</st>
<p>We searched MEDLINE and EMBASE for studies published from 1 January 2006 to 31 December 2010.</p>
</sec>
<sec><st>Eligibility criteria for included studies</st>
<p>We included prospective cohort, case&ndash;control studies or retrospective analyses of databases or disease registers where the effect of risk factors for mortality or survival was examined. Studies must have included more than 1000 participants receiving RBCT for any cause. We assessed the effects of RBCT versus no RBCT and different volumes and age of RBCT.</p>
</sec>
<sec><st>Results</st>
<p>&ndash;32 studies were included in the review; 23 assessed the effects of RBCT versus no RBCT; 5 assessed different volumes and 4 older versus newer RBCT. There was a considerable variability in the patient populations, study designs and level of statistical adjustment. Overall, most studies showed a higher rate of mortality when comparing patients who received RBCT with those who did not, even when these rates were adjusted for confounding; the majority of these increases were statistically significant. The same pattern was observed in studies where protection from bias was likely to be greater, such as prospective studies.</p>
</sec>
<sec><st>Conclusions</st>
<p>Recent observational studies do show a consistently adverse effect of RBCT on mortality. Whether this is a true effect remains uncertain as it is possible that even the best conducted adjustments cannot completely eliminate the impact of confounding.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Hopewell, S., Omar, O., Hyde, C., Yu, L.-M., Doree, C., Murphy, M. F.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002154</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002154</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Evidence based practice, Haematology (incl blood transfusion)]]></dc:subject>
<dc:title><![CDATA[A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002154</prism:startingPage>
<prism:endingPage>e002154</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002203?rss=1">
<title><![CDATA[Prevalence of most at risk groups of HIV/AIDS]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002203?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The aim of this study was to develop a framework and best estimates of prevalence for the most at risk populations (MARPs) for HIV/AIDS to include sex workers (SW), men who have sex with men (MSM) and injecting drug users (IDUs) in order to evaluate national HIV/AIDS programmatic targets across the Republic of Serbia.</p>
</sec>
<sec><st>Design</st>
<p>A national, cross-sectional study and direct enumeration, multiplier and benchmark methods with integrated bio-behavioural surveys, capture/recapture and methods with Wald and Clopper-Pearson CIs were used.</p>
</sec>
<sec><st>Setting</st>
<p>This study was carried out in the three largest cities and main regions of Serbia, the capital city, Belgrade, (population 1&nbsp;639&nbsp;121 persons), the Vojvodina region with main city Novi Sad (population 335&nbsp;701) and the rest of Serbia with main city Nis (population 257&nbsp;867).</p>
</sec>
<sec><st>Participants</st>
<p>A total of 1301 respondents from the defined MARPs completed the survey in the 2009/2010 period across the three cities.</p>
</sec>
<sec><st>Primary outcome measures</st>
<p>Estimates of the hidden numbers at risk of HIV/AIDS.</p>
</sec>
<sec><st>Results</st>
<p>It was estimated that there were 1775&ndash;6027 SW between 18 and 49&nbsp;years in Serbia in 2009. For MSM, national estimates for 2009 ranged from 20&nbsp;789 to 90&nbsp;104 individuals aged between 20 and 49&nbsp;years. For IDU, a possible range of 12&nbsp;682&ndash;48&nbsp;083 individuals aged between 15 and 59&nbsp;years in 2009 was estimated.</p>
</sec>
<sec><st>Conclusions</st>
<p>For service planning across Central and Eastern Europe, it is important to highlight how credible estimates can be achieved and compared with numbers within HIV/AIDS-prevention programmes. Within needle exchange programmes, only 5.4&ndash;20.5% of the estimated population was observed and this proportion was lower within methadone treatment data. Results have implications for future IDU treatment and HIV incidence and spread across all populations at risk.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Comiskey, C., Dempsey, O., Simic, D., Baros, S.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002203</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002203</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Public health, Sexual health, HIV AIDS]]></dc:subject>
<dc:title><![CDATA[Injecting drug users, sex workers and men who have sex with men: a national cross-sectional study to develop a framework and prevalence estimates for national HIV/AIDS programmes in the Republic of Serbia]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002203</prism:startingPage>
<prism:endingPage>e002203</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002266?rss=1">
<title><![CDATA[The INCA study protocol]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002266?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Studies on patient involvement show that physicians make few attempts to involve their patients who ask few questions if not facilitated. On the other hand, the patients who participate in the decision-making process show greater treatment adherence and have better health outcomes. Different methods to encourage the active participation during oncological consultation have been described; however, similar studies in Italy are lacking. The aims of the present study are to (1) assess the effects of a preconsultation intervention to increase the involvement of breast cancer patients during the consultation, and (2) explore the role of the attending companions in the information exchange during consultation.</p>
</sec>
<sec><st>Methods and analysis</st>
<p>All female patients with breast cancer who attend the Oncology Out-patient Services for the first time will provide an informed consent to participate in the study. They are randomly assigned to the intervention or to the control group. The intervention consists of the presentation of a list of relevant illness-related questions, called a question prompt sheet. The primary outcome measure of the efficacy of the intervention is the number of questions asked by patients during the consultation. Secondary outcomes are the involvement of the patient by the oncologist; the patient's perceived achievement of her information needs; the patient's satisfaction and ability to cope; the quality of the doctor&ndash;patient relationship in terms of patient-centeredness; and the number of questions asked by the patient's companions and their involvement during the consultation. All outcome measures are supposed to significantly increase in the intervention group.</p>
</sec>
<sec><st>Ethics and dissemination</st>
<p>The study was approved by the local Ethics Committee of the Hospital Trust of Verona. Study findings will be disseminated through peer-reviewed publications and conference presentations.</p>
</sec>
<sec><st>Trial registration</st>
<p>ClinicalTrials.gov identifier: NCT01510964</p>
</sec>
]]></description>
<dc:creator><![CDATA[Goss, C., Ghilardi, A., Deledda, G., Buizza, C., Bottacini, A., Del Piccolo, L., Rimondini, M., Chiodera, F., Mazzi, M. A., Ballarin, M., Bighelli, I., Strepparava, M. G., Molino, A., Fiorio, E., Nortilli, R., Caliolo, C., Zuliani, S., Auriemma, A., Maspero, F., Simoncini, E. L., Ragni, F., Brown, R., Zimmermann, C.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002266</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002266</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Oncology, Patient-centred medicine]]></dc:subject>
<dc:title><![CDATA[INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocol]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Protocol</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002266</prism:startingPage>
<prism:endingPage>e002266</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002297?rss=1">
<title><![CDATA[Quality of care in type 2 diabetes]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002297?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>This study investigates associations between healthcare personnel's perceived job strain, supervisor support and the outcome of care in terms of glycaemic control among patients with type 2 diabetes.</p>
</sec>
<sec><st>Design</st>
<p>A cross-sectional study from 2006.</p>
</sec>
<sec><st>Setting</st>
<p>18 primary care health centres (HCs) from five municipalities in Finland.</p>
</sec>
<sec><st>Participants</st>
<p>Aggregated survey data on perceived job strain and supervisor support from healthcare personnel (doctors, n=122, mean age 45.5&nbsp;years, nurses, n=300, mean age 47.1&nbsp;years) were combined with registered data (Electronic Medical Records) from 8975 patients (51% men, mean age 67&nbsp;years) with type 2 diabetes.</p>
</sec>
<sec><st>Outcome measure</st>
<p>Poor glycaemic control (glycated haemoglobin (HbA1c) &ge;7%).</p>
</sec>
<sec><st>Results</st>
<p>The mean HbA1c level among patients with type 2 diabetes was 7.1 (SD 1.2, range 4.5&ndash;19.1), and 43% had poor glycaemic control (HbA1c &ge;7%). Multilevel logistic regression analyses, adjusted for patient's age and sex, and HC and HC service area-level characteristics, showed that patients&rsquo; HbA1c-levels were less optimal in high-strain HCs than in low-strain HCs (OR 1.44, 95% CI 1.12 to 1.86). Supervisor support in HCs was not associated with the outcome of care.</p>
</sec>
<sec><st>Conclusions</st>
<p>The level of job strain among healthcare personnel may play a role in achieving good glycaemic control among patients with type 2 diabetes.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Koponen, A., Vahtera, J., Pitkaniemi, J., Virtanen, M., Pentti, J., Simonsen-Rehn, N., Kivimaki, M., Suominen, S.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002297</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002297</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Diabetes and endocrinology, Health services research, Occupational and environmental medicine, Public health]]></dc:subject>
<dc:title><![CDATA[Job strain and supervisor support in primary care health centres and glycaemic control among patients with type 2 diabetes: a cross-sectional study]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002297</prism:startingPage>
<prism:endingPage>e002297</prism:endingPage>
</item>
<item rdf:about="http://bmjopen.bmj.com/cgi/content/short/3/5/e002346?rss=1">
<title><![CDATA[Survey of attitudes towards specialist care]]></title>
<link>http://bmjopen.bmj.com/cgi/content/short/3/5/e002346?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To examine the attitudes of UK healthcare professionals towards what they believe constitutes specialist care for teenage and young adult (TYA) patients with cancer, to determine which factors they considered to be the most important components of specialist TYA care, and whether opinion varied between clinical specialties and reflected the drivers for care improvements within National Health Service (NHS) policy.</p>
</sec>
<sec><st>Design and methods</st>
<p>The study utilised a cross-sectional survey, using Likert scales, to assess attitudes towards specialist care. Responses were grouped using model-based clustering methods implemented in LatentGold 4.5.</p>
</sec>
<sec><st>Setting</st>
<p>Participants from 98 NHS trusts in the UK were invited to participate in the study.</p>
</sec>
<sec><st>Participants</st>
<p>691 healthcare professionals involved in the management of TYA patients were approached; of these, 338 responded.</p>
</sec>
<sec><st>Results</st>
<p>338 healthcare professionals responded (51.9% of those invited). Responses were grouped into three clusters according to the pattern of responses to the questions. One cluster rated age-appropriate care above all else, the second rated both age and site-appropriate care highly while the third assigned more importance to site-specific care. Overall, the psychosocial and supportive aspects of care were rated highest while statements relating to factors known to be important (access to clinical trials, treatment at a high volume centre and specialist diagnostics) were not rated as highly as expected.</p>
</sec>
<sec><st>Conclusions</st>
<p>Attitudes varied widely between professionals treating TYA patients with cancer as to what constitutes key aspects of specialist care. Further work is needed to quantify the extent to which this influences practice.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Birch, R. J., Morris, E. J. A., West, R. M., Stark, D. P., Lewis, I., Morgan, S., Feltbower, R. G.]]></dc:creator>
<dc:date>2013-05-02T22:10:03-07:00</dc:date>
<dc:identifier>info:doi/10.1136/bmjopen-2012-002346</dc:identifier>
<dc:identifier>hwp:master-id:bmjopen;bmjopen-2012-002346</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:subject><![CDATA[Open access, Oncology, Qualitative research]]></dc:subject>
<dc:title><![CDATA[A cross-sectional survey of healthcare professionals to determine what they believe constitutes 'specialist' care for teenage and young adult patients with cancer]]></dc:title>
<prism:publicationDate>2013-05-02</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>3</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>e002346</prism:startingPage>
<prism:endingPage>e002346</prism:endingPage>
</item>
</rdf:RDF>